Industries > Pharma > Biologics Market Report 2020-2030
Biologics Market Report 2020-2030
Forecast by Product Type (Monoclonal Antibodies (Humira, Remicide, Tysabri, Herceptin, Kadcyla, Perjeta, Opdivo, Keytruda, Avastin), Vaccines, Protein Therapeutics (Insulin, Other Recombinant Hormones, Plasma & Recombinant Coagulation Factors, Interferons, Enzyme Replacement & Other Protein Therapies), Regenerative Medicines (Stem Cell Therapy, Tissue Engineered Products, Gene Therapies), Fusion Proteins), by Application (Oncology, Autoimmune Diseases, Infectious Diseases, Cardiovascular Disorders, Haematological Disorders, Others), by Manufacturing (Outsourced, In-house), and Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) PLUS Profiles of Leading Biologics Companies and COVID-19 Impact Scenarios
PUBLISHED: 04 August 2020
PAGES: 720
PRODUCT CODE: PHA0790
SUBMARKET:
Biotechnology Therapeutic Drugs
SKU: PHA0790
Categories: Biotechnology, Pharma, Therapeutic Drugs
Tags: PHA0790, PHA1016, PHA1024, PHA1122
Biologics–our new study reveals trends, R&D progress, and predicted revenues
Where is the Biologics market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 710+ page report provides 500+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biologics Market. See how to exploit the opportunities.
Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT, Porter’s, PEST Analysis, product profiles and commercial developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
To access the data contained in this document please email contactus@visiongain.com
Discover sales predictions for the world market and submarkets
By Product Type
• Monoclonal Antibodies
– Humira
– Remicide
– Tysabri
– Herceptin
– Kadcyla
– Perjeta
– Opdivo
– Keytruda
– Avastin
• Vaccines
• Protein Therapeutics
– Insulin:
• Lantus
• Novolog/NovoRapid
• Humalog
• Levemir
• Apidra
– Other Recombinant Hormones
– Plasma & Recombinant Coagulation Factors
– Interferons:
• Avonex
• Rebif
– Enzyme Replacement & Other Protein Therapies
• Regenerative Medicines
– Stem Cell Therapy:
• Osteocel Plus
• Trinity Evolution & Trinity Elite
– Tissue Engineered Products:
• Apligraft
• Demagraft
– Gene Therapies (IMIGYLC)
• Fusion Proteins
– Enbrel
– Eylea
By Application
• Oncology
• Autoimmune Diseases
• Infectious Diseases
• Cardiovascular Disorders
• Haematological Disorders
• Others
By Manufacturing
• Outsourced
• In-house
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 16 leading national markets:
By Region
• North America
– U.S.
– Canada
• Europe
– Germany
– France
– UK
– Italy
– Spain
– Russia
– Rest of Europe
• Asia Pacific
– Japan
– China
– India
– Australia
– Rest of Asia Pacific
• Latin America
– Brazil
– Mexico
– Rest of Latin America
• Middle East & Africa (MEA)
– GCC
– South Africa
– Rest of Middle East & Africa
Leading companies and the potential for market growth
Overall world revenue for Biologics Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Biologics Market report helps you
In summary, our 710+ page report provides you with the following knowledge:
• Revenue forecasts to 2030 for Biologics Market, with forecasts for Product Type, Application and Manufacturing, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2030 for 5 regional and 16 key national markets – See forecasts for the Biologics market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, GCC Countries and South Africa.
• Prospects for established firms and those seeking to enter the market– including company profiles for 23 of the major companies involved in the Biologics Market. Some of the company’s profiles in this report include GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Novartis AG, Pfizer Inc., Sanofi S.A., Novo Nordisk A/S, Takeda Pharmaceutical, Gilead Sciences, Regeneron Pharmaceuticals, Inc., Biogen, AbbVie, and Amgen among other prominent players
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Biologics Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Biologics Market Report 2020-2030: Forecast by Product Type (Monoclonal Antibodies (Humira, Remicide, Tysabri, Herceptin, Kadcyla, Perjeta, Opdivo, Keytruda, Avastin), Vaccines, Protein Therapeutics (Insulin, Other Recombinant Hormones, Plasma & Recombinant Coagulation Factors, Interferons, Enzyme Replacement & Other Protein Therapies), Regenerative Medicines (Stem Cell Therapy, Tissue Engineered Products, Gene Therapies), Fusion Proteins), by Application (Oncology, Autoimmune Diseases, Infectious Diseases, Cardiovascular Disorders, Haematological Disorders, Others), by Manufacturing (Outsourced, In-house), and Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) PLUS Profiles of Leading Biologics Companies and COVID-19 Impact Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Introduction to Biologics Market
1.1. Global Biologics Market Segmentation
1.2 Biologics Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.1.1 Impact of COVID 19 on Global Pharma Supply Chain
1.7.1.2 Worldwide air transportation availability and costs
1.7.1.3 Return of pharmaceutical manufacturing back to the US
1.7.1.4 Possible supply disruptions of drugs identified as potential treatments against COVID-19
1.7.1.5 Prescription refills
1.7.1.6 Impact of pharmaceutical companies in clinical need
1.7.1.7 Battle for cure
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Market Size Estimation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Drivers
3.1.1 Ability to command high prices
3.1.2 Aging population and the rise of chronic disease
3.1.3 Product launches will drive biologics market
3.1.4 Rise in prevalence of chronic diseases
3.2 Restraints
3.2.1 Difficulty in manufacturing biologics
3.2.2 Stringent regulatory process and high capital investment
3.2.3 High costs in the face of declining national healthcare budgets
3.3 Opportunities
3.3.1 Application of biologics in complex diseases
3.3.2 Rising demand for next generation biologics
3.3.3 Consolidation growing in the industry
3.3.4 Pleasant policy controls
3.3.5 Strong pipeline of biologics drugs
3.4 Challenges
3.4.1 Risk and damage to supply chain due to COVID-19
3.4.2 Development of promising biological molecule into an effective product
3.4.3 Biosimilars – both an opportunity and a threat
3.5 Trends
3.5.1 Growing strategic partnerships in China
3.5.2 Outsourcing strategies
3.6 Porter’s Five Forces Analysis
3.6.1 Competitive Rivalry - High
3.6.2 Threat of New Entrants - Low
3.6.3 Bargaining Power of Suppliers - Low
3.6.4 Bargaining Power of Buyers - Medium
3.6.5 Threat of Substitutes – Medium/Low
3.7 SWOT Analysis
3.7.1 Strengths
3.7.2 Weaknesses
3.7.3 Opportunities
3.7.4 Threats
3.8 PEST Analysis
3.8.1 Political
3.8.2 Economical
3.8.3 Social
3.8.4 Technological
4 Global Biologics Market Size Forecast 2020-2030 by Product Type
4.1 Global Biologics Market for Monoclonal Antibodies Segment: Revenue Forecast 2020-2030
4.1.1 Monoclonal Antibodies Sub-market: Scientific and Historical Background
4.1.1.1 Natural Antibodies: Key to the Immune System
4.1.1.2 From serum therapy to monoclonal antibodies
4.1.1.3 Humanising the mAb
4.1.1.4 MAbs have found success in treating autoimmune disorders, cancers and other diseases – Great potential for the future
4.1.1.5 MAbs for All? Technologies Come Off Patent
4.1.2 Global Biologics Market for Monoclonal Antibodies Segment: Recovery Forecasts (V,U, W, L)
4.1.3 Autoimmune mAbs
4.1.3.1 Humira – The World’s Best-Selling Prescription Drug
4.1.3.1.1 Expanded Indications for Humira
4.1.3.1.2 Biosimilar Adalimumab: Patents Protect Humira in Developed Markets for Now
4.1.4 Global Biologics Market for Humira Segment: Recovery Forecasts (V,U, W, L)
4.1.4.1 Remicade: A Treatment for Immune-mediated Inflammatory Diseases
4.1.4.1.1 Patent Dance in the US
4.1.4.1.2 Biosimilar Infliximab: Multiple Launches
4.1.5 Global Biologics Market for Remicade Segment: Recovery Forecasts (V,U, W, L)
4.1.5.1 Tysabri: Blockbuster Drug’s High Efficacy Offsets its Risks
4.1.6 Global Biologics Market for Tysabri Segment: Recovery Forecasts (V,U, W, L)
4.1.7 Oncology mAbs
4.1.7.1 Past Approvals
4.1.7.2 Rising Incidence of Cancer Will Drive Demand
4.1.7.3 Rituxan: The World’s Leading Anti-Cancer mAb
4.1.7.4 Biosimilar Rituximab: Two Candidates Await Approval in Europe
4.1.7.5 Avastin: Growing under CER, Through New Indications
4.1.7.5.1 Controversy over Off-Label Avastin use: Roche is Backed up by Incidents in India, and Opinion of EFPIA
4.1.7.5.2 Biosimilar Bevacizumab: Late Patent Expiry is a Blessing for Roche, Although Various Biosimilars in Development
4.1.8 Global Biologics Market for Avastin Segment: Recovery Forecasts (V,U, W, L)
4.1.8.1 Herceptin: Breast Cancer Blockbuster
4.1.8.1.1 Pricing Challenges in Emerging Markets
4.1.8.1.2 Roche Builds Franchise of Anti-HER2 mAbs Around Herceptin
4.1.8.1.3 Biosimilar Trastuzumab
4.1.9 Global Biologics Market for Herceptin Segment: Recovery Forecasts (V,U, W, L)
4.1.9.1 Kadcyla
4.1.9.1.1 Mixed Results from Different Clinical Trials
4.1.9.1.2 Kadcyla Sales Forecast 2020 -2030
4.1.10 Global Biologics Market for Kadcyla Segment: Recovery Forecasts (V,U, W, L)
4.1.10.1 Perjeta
4.1.10.1.1 Positive Results from Different Clinical Trials
4.1.11 Global Biologics Market for Perjeta Segment: Recovery Forecasts (V,U, W, L)
4.1.11.1 Opdivo: Big Potential for Bristol-Myer Squibb’s PD-1 Inhibitor
4.1.12 Global Biologics Market for Opdivo Segment: Recovery Forecasts (V,U, W, L)
4.1.12.1 Keytruda
4.1.13 Global Biologics Market for Keytruda Segment: Recovery Forecasts (V,U, W, L)
4.1.13.1.1 Good News and Bad News for NSCLC from CheckMate Trials
4.1.13.1.2 Cyramza (Eli Lilly): Approved in Three Additional Indications Since its First Approval in April 2014.
4.1.13.2 Oncology mAbs: New Approvals and Pipeline
4.1.13.2.1 Empliciti (Elotuzumab) by Bristol-Myers Squibb and AbbVie): Recently Approved
4.1.13.2.2 Unituxin (United Therapeutics) Receives FDA Approval March 2015
4.1.13.2.3 SAR3419 (coltuximab ravtansine) (anti-CD19, Sanofi)
4.2 Global Biologics Market for Vaccines Segment: Revenue Forecast 2020-2030
4.2.1 Global Biologics Market for Vaccines Segment: Recovery Forecasts (V,U, W, L)
4.3 Global Biologics Market for Protein Therapeutics Segment: Revenue Forecast 2020-2030
4.3.1 Global Biologics Market for Protein Therapeutics Segment: Recovery Forecasts (V,U, W, L)
4.3.2 Global Biologics Market for Insulin Sub Segment: Revenue Forecast 2020-2030
4.3.3 Global Biologics Market for Insulin Segment: Recovery Forecasts (V,U, W, L)
4.3.3.1 Lantus
4.3.4 Global Biologics Market for Lantus Segment: Recovery Forecasts (V,U, W, L)
4.3.4.1 NovoLog/NovoRapid
4.3.5 Global Biologics Market for Novolog Segment: Recovery Forecasts (V,U, W, L)
4.3.5.1 Humalog
4.3.6 Global Biologics Market for Humalog Segment: Recovery Forecasts (V,U, W, L)
4.3.6.1 Levemir
4.3.7 Global Biologics Market for Levemir Segment: Recovery Forecasts (V,U, W, L)
4.3.7.1 Apidra
4.3.8 Global Biologics Market for Apidra Segment: Recovery Forecasts (V,U, W, L)
4.3.9 Other Recombinant Hormones: Erythropoietins, G-CSF and Human Growth Hormone
4.3.10 Global Biologics Market for Other Recombinant Hormones Segment: Recovery Forecasts (V,U, W, L)
4.3.10.1 Erythropoietin
4.3.10.2 G-CSF
4.3.10.3 Human Growth Hormones
4.3.10.4 Plasma and Recombinant Coagulating Factors
4.3.11 Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment: Recovery Forecasts (V,U, W, L)
4.3.11.1 Interferons
4.3.12 Global Biologics Market for Interferons Segment: Recovery Forecasts (V,U, W, L)
4.3.12.1.1 Avonex
4.3.13 Global Biologics Market for Avonex Segment: Recovery Forecasts (V,U, W, L)
4.3.13.1.1 Rebif
4.3.14 Global Biologics Market for Rebif Segment: Recovery Forecasts (V,U, W, L)
4.3.14.1.1 Betaseron
4.3.14.1.2 Plegridy
4.3.14.2 Enzyme Replacement and Other Protein Therapies
4.3.15 Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment: Recovery Forecasts (V,U, W, L)
4.4 Global Biologics Market for Regenerative Medicines Segment: Revenue Forecast 2020-2030
4.4.1 Global Biologics Market for Regenerative Medicines Segment: Recovery Forecasts (V,U, W, L)
4.4.2 Stem Cell Therapies
4.4.2.1 Stem Cells: Scientific Breakdown
4.4.3 Stem Cell Therapies
4.4.3.1 Haematopoietic Stem Cell Transplantation:
4.4.3.2 From Procedures to Products: Cord Blood Stem Cell Approvals
4.4.4 Global Biologics Market for Stem Cell Therapy Segment: Recovery Forecasts (V,U, W, L)
4.4.4.1 Osteocel Plus: The Leading Stem Cell Orthobiologic
4.4.5 Global Biologics Market for Osteocel Plus Segment: Recovery Forecasts (V,U, W, L)
4.4.5.1 Trinity Evolution and Trinity Elite
4.4.5.1.1 Trinity Evolution and Trinity Elite Revenue Forecast to 2030
4.4.6 Global Biologics Market for Trinity Evolution & Trinity Elite Segment: Recovery Forecasts (V,U, W, L)
4.4.6.1.1 MSC-100-IV (Previously Known as Prochymal): World’s First Approved Stem Cell Drug Outside of South Korea
4.4.6.1.2 An Important Role to Play in the Future of HSCT, and also Wins Approval in Japan through Partner
4.4.6.1.3 CARTISTEM (MEDIPOST): The World’s First Allogeneic Stem Cell Drug
4.4.6.1.4 Hearticellgram-AMI (PharmaCell B.V.): One of the First Approved Cardiovascular Stem Cell Treatments in the World.
4.4.7 Tissue Engineering Therapies
4.4.7.1 Tissue Engineering – In Vitro Manipulation for Therapeutic Purposes
4.4.7.2 Current Status of the Market
4.4.8 Global Biologics Market for Tissue Engineered Products Segment: Recovery Forecasts (V,U, W, L)
4.4.8.1 Apligraf: The Leading Product
4.4.8.2 Apligraf’s role in Wound Healing
4.4.9 Global Biologics Market for Dermagraft Segment: Recovery Forecasts (V,U, W, L)
4.4.9.1 ReCell
4.4.9.2 MySkin and CyroSkin
4.4.10 Global Biologics Market for Apligraft Segment: Recovery Forecasts (V,U, W, L)
4.4.10.1 Dermagraft: Organogenesis Further Strengthens Position Through this 2014 Acquisition
4.4.11 Tissue Engineering Therapies Pipeline
4.4.11.1 NeoCart by Histogenics: Undergoing Phase 3 Trial for Knee Cartilage Repair
4.4.11.2 Extracorporeal Bio-Artificial Liver Therapy by Vital Therapies
4.4.11.3 StrataGraft by Stratatech Corporation Demonstrates Positive Top-Line Results
4.4.12 Gene Therapies
4.4.12.1 Gene Therapy: Historical and Scientific Background
4.4.12.2 Harnessing Infectivity: Viral Vectors in Gene Therapy
4.4.12.3 Approved Gene Therapy Products
4.4.12.3.1 Gendicine: The World’s First Commercial Gene Therapy Product
4.4.12.3.2 Oncorine: First Oncolytic Viral Therapy
4.4.12.3.3 Neovasculgen: Russia’s First Gene Therapy
4.4.12.3.4 Neovasculgen: Drop in Revenues in 2015, but HSCI Predicts Notable Increases as Product is Added to VED List
4.4.12.3.5 Glybera: The First Gene Therapy for Western Markets, Although Has Abandoned Hope of Receiving FDA-Approval
4.4.12.4 IMLYGIC
4.4.12.4.1 IMLYGIC: Clinical Trials and Development Efforts
4.4.13 Global Biologics Market for IMIGYLC Segment: Recovery Forecasts (V,U, W, L)
4.5 Global Biologics Market for Fusion Proteins Segment: Revenue Forecast 2020-2030
4.5.1 Scientific and Historical Background
4.5.1.1 Differentiating Fusion Proteins
4.5.2 Global Biologics Market for Fusion Proteins Segment: Recovery Forecasts (V,U, W, L)
4.5.3 Enbrel: The First FP to be Approved, in 1998
4.5.3.1 Gradually Approved for Additional Indications
4.5.3.2 Enbrel Granted Extended Patent Protection in the US, Patent has Expired in EU
4.5.3.3 Multiple Biosimilars Available in Emerging Markets
4.5.4 Global Biologics Market for Enbrel Segment: Recovery Forecasts (V,U, W, L)
4.5.5 Eylea: Blockbuster FP Treatment for Wet AMD
4.5.6 Global Biologics Market for Eylea Segment: Recovery Forecasts (V,U, W, L)
4.5.7 Fusion Proteins Pipeline
4.5.7.1 Sotatercept by Acceleron Pharma and Celgene Corporation - Currently Undergoing Eight Clinical Trials
4.5.7.2 Blisibimod (Anthera Pharmaceuticals) for the Treatment of Various Autoimmune Diseases, in Late Stage Development
5 Global Biologics Market Size Forecast 2020-2030 by Application Type
5.1 Global Biologics Market for Oncology Segment: Revenue Forecast 2020-2030
5.1.1 Global Biologics Market for Oncology Segment: Recovery Forecasts (V,U, W, L)
5.2 Global Biologics Market for Autoimmune Diseases Segment: Revenue Forecast 2020-2030
5.2.1 Global Biologics Market for Autoimmune Diseases Segment: Recovery Forecasts (V,U, W, L)
5.3 Global Biologics Market for Infectious Diseases Segment: Revenue Forecast 2020-2030
5.3.1 Global Biologics Market for Infectious Diseases Segment: Recovery Forecasts (V,U, W, L)
5.4 Global Biologics Market for Cardiovascular Disorders Segment: Revenue Forecast 2020-2030
5.4.1 Global Biologics Market for Cardiovascular Disorders Segment: Recovery Forecasts (V,U, W, L)
5.5 Global Biologics Market for Hematological Disorders Segment: Revenue Forecast 2020-2030
5.5.1 Global Biologics Market for Hematological Disorders Segment: Recovery Forecasts (V,U, W, L)
5.6 Global Biologics Market for Others Segment: Revenue Forecast 2020-2030
5.6.1 Global Biologics Market for Others Segment: Recovery Forecasts (V,U, W, L)
6 Global Biologics Market Size Forecast 2020-2030 by Manufacturing
6.1 Global Biologics Market for Outsourced Manufacturing Segment: Revenue Forecast 2020-2030
6.1.1 Global Biologics Market for Outsourced Manufacturing Segment: Recovery Forecasts (V,U, W, L)
6.2 Global Biologics Market for In-house Manufacturing Segment: Revenue Forecast 2020-2030
6.2.1 Global Biologics Market for In-house Manufacturing Segment: Recovery Forecasts (V,U, W, L)
7 Regional and Leading National Biologics Market Forecasts 2020-2030
7.1 Global Biologics Market by National Market Forecast 2020-2030
7.1.1 Global Biologics Market Forecast 2020-2030, Recovery Scenarios
8 North America
8.1 North America Biologics Market Forecast by Country, 2020-2030
8.2 North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
8.2.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
8.3 North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
8.3.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
8.4 North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
8.4.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
8.5 U.S. Biologics Market Forecast 2020-2030
8.5.1 U.S. Biologics Market: Recovery Scenarios
8.6 Canada Biologics Market Forecast 2020-2030
8.6.1 Canada Biologics Market: Recovery Scenarios
9 Europe
9.1 Europe Biologics Market Forecast by Country, 2020-2030
9.2 Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
9.2.1 Recovery Scenarios (V, U, W, L) Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
9.3 Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
9.3.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
9.4 Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
9.4.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
9.5 Germany Biologics Market Forecast 2020-2030
9.5.1 Germany Biologics Market: Recovery Scenarios
9.6 UK Biologics Market Forecast 2020-2030
9.6.1 UK Biologics Market: Recovery Scenarios
9.7 France Biologics Market Forecast 2020-2030
9.7.1 France Biologics Market: Recovery Scenarios
9.8 Italy Biologics Market Forecast 2020-2030
9.8.1 Italy Biologics Market: Recovery Scenarios
9.9 Spain Biologics Market Forecast 2020-2030
9.9.1 Spain Biologics Market: Recovery Scenarios
9.10 Russia Biologics Market Forecast 2020-2030
9.10.1 Russia Biologics Market: Recovery Scenarios
9.11 RoE Biologics Market Forecast 2020-2030
9.11.1 RoE Biologics Market: Recovery Scenarios
10 Asia-Pacific
10.1 Asia-Pacific Biologics Market Forecast by Country, 2020-2030
10.2 Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
10.2.1 Recovery Scenarios (V, U, W, L): Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
10.3 Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
10.3.1 Recovery Scenarios (V, U, W, L): Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
10.4 Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
10.4.1 Recovery Scenarios (V, U, W, L): Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
10.5 Japan Biologics Market Forecast 2020-2030
10.5.1 Japan Biologics Market: Recovery Scenarios
10.6 China Biologics Market Forecast 2020-2030
10.6.1 China Biologics Market: Recovery Scenarios
10.7 India Biologics Market Forecast 2020-2030
10.7.1 India Biologics Market: Recovery Scenarios
10.8 Australia Biologics Market Forecast 2020-2030
10.8.1 Australia Biologics Market: Recovery Scenarios
10.9 RoAP Biologics Market Forecast 2020-2030
10.9.1 RoAP Biologics Market: Recovery Scenarios
11 Latin America
11.1 Latin America Biologics Market Forecast by Country, 2020-2030
11.2 Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
11.2.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
11.3 Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
11.3.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
11.4 Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
11.4.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
11.5 Brazil Biologics Market Forecast 2020-2030
11.5.1 Brazil Biologics Market: Recovery Scenarios
11.6 Mexico Biologics Market Forecast 2020-2030
11.6.1 Mexico Biologics Market: Recovery Scenarios
11.7 RoLA Biologics Market Forecast 2020-2030
11.7.1 RoLA Biologics Market: Recovery Scenarios
12 Middle East and Africa
12.1 MEA Biologics Market Forecast by Country, 2020-2030
12.2 MEA Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
12.2.1 Recovery Scenarios (V, U, W, L): Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
12.3 MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
12.3.1 Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
12.4 MEA Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
12.4.1 Recovery Scenarios (V, U, W, L): Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
12.5 GCC Biologics Market Forecast 2020-2030
12.5.1 GCC Biologics Market: Recovery Scenarios
12.6 South Africa Biologics Market Forecast 2020-2030
12.6.1 South Africa Biologics Market: Recovery Scenarios
12.7 RoMEA Biologics Market Forecast 2020-2030
12.7.1 RoMEA Biologics Market: Recovery Scenarios
13 Leading Companies in the Biologics Market
13.1 GlaxoSmithKline Plc
13.1.1 GlaxoSmithKline Plc: Company Snapshot
13.1.2 GlaxoSmithKline Plc: Company Overview
13.1.3 GlaxoSmithKline Plc Financials, 2015-2019
13.1.4 GlaxoSmithKline Plc: Product Portfolio
13.1.5 GlaxoSmithKline Plc: Recent Developments
13.2 Johnson & Johnson Services, Inc
13.2.1 Johnson & Johnson Services, Inc: Company Snapshot
13.2.2 Johnson & Johnson Services, Inc: Company Overview
13.2.3 Johnson & Johnson Services, Inc Financials, 2015-2019
13.2.4 Johnson & Johnson Services, Inc: Product Portfolio
13.2.5 Johnson & Johnson Services, Inc: Recent Developments
13.3 Merck & Co
13.3.1 Merck & Co: Company Snapshot
13.3.2 Merck & Co: Company Overview
13.3.3 Merck & Co Financials, 2015-2019
13.3.4 Merck & Co: Product Portfolio
13.3.5 Merck & Co: Recent Developments
13.4 Novartis AG
13.4.1 Novartis AG: Company Snapshot
13.4.2 Novartis AG: Company Overview
13.4.3 Novartis AG Financials, 2015-2019
13.4.4 Novartis AG: Product Portfolio
13.4.5 Novartis AG: Recent Developments
13.5 Pfizer Inc
13.5.1 Pfizer Inc: Company Snapshot
13.5.2 Pfizer Inc: Company Overview
13.5.3 Pfizer Inc Financials, 2015-2019
13.5.4 Pfizer Inc: Product Portfolio
13.5.5 Pfizer Inc: Recent Developments
13.6 Sanofi S.A
13.6.1 Sanofi S.A: Company Snapshot
13.6.2 Sanofi S.A: Company Overview
13.6.3 Sanofi S.A Financials, 2015-2019
13.6.4 Sanofi S.A: Product Portfolio
13.6.5 Sanofi S.A: Recent Developments
13.7 Novo Nordisk A/S
13.7.1 Novo Nordisk A/S: Company Snapshot
13.7.2 Novo Nordisk A/S: Company Overview
13.7.3 Novo Nordisk A/S Financials, 2015-2019
13.7.4 Novo Nordisk A/S: Product Portfolio
13.7.5 Novo Nordisk A/S: Recent Developments
13.8 Takeda Pharmaceutical
13.8.1 Takeda Pharmaceutical: Company Snapshot
13.8.2 Takeda Pharmaceutical: Company Overview
13.8.3 Takeda Pharmaceutical Financials, 2015-2019
13.8.4 Takeda Pharmaceutical: Product Portfolio
13.8.5 Takeda Pharmaceutical: Recent Developments
13.9 Gilead Sciences Inc
13.9.1 Gilead Sciences Inc: Company Snapshot
13.9.2 Gilead Sciences Inc: Company Overview
13.9.3 Gilead Sciences Inc Financials, 2015-2019
13.9.4 Gilead Sciences Inc: Product Portfolio
13.9.5 Gilead Sciences Inc: Recent Developments
13.10 Alexion Pharmaceuticals, Inc
13.10.1 Alexion Pharmaceuticals, Inc: Company Snapshot
13.10.2 Alexion Pharmaceuticals, Inc: Company Overview
13.10.3 Alexion Pharmaceuticals, Inc Financials, 2015-2019
13.10.4 Alexion Pharmaceuticals, Inc: Product Portfolio
13.10.5 Alexion Pharmaceuticals, Inc: Recent Developments
13.11 UCB SA
13.11.1 UCB SA: Company Snapshot
13.11.2 UCB SA: Company Overview
13.11.3 UCB SA Financials, 2015-2019
13.11.4 UCB SA: Product Portfolio
13.11.5 UCB SA: Recent Developments
13.12 Samsung Biologics Co., Ltd
13.12.1 Samsung Biologics Co., Ltd: Company Snapshot
13.12.2 Samsung Biologics Co., Ltd: Company Overview
13.12.3 Samsung Biologics Co., Ltd Financials, 2015-2019
13.12.4 Samsung Biologics Co., Ltd: Product Portfolio
13.12.5 Samsung Biologics Co., Ltd: Recent Developments
13.13 NEKTAR THERAPEUTICS
13.13.1 NEKTAR THERAPEUTICS: Company Snapshot
13.13.2 NEKTAR THERAPEUTICS: Company Overview
13.13.3 NEKTAR THERAPEUTICS Inc. Financials, 2015-2019
13.13.4 NEKTAR THERAPEUTICS: Product Portfolio
13.13.5 NEKTAR THERAPEUTICS: Recent Developments
13.14 REGENERON PHARMACEUTICALS, INC.
13.14.1 REGENERON PHARMACEUTICALS, INC.: Company Snapshot
13.14.2 REGENERON PHARMACEUTICALS, INC.: Company Overview
13.14.3 REGENERON PHARMACEUTICALS, INC. Financials, 2015-2019
13.14.4 REGENERON PHARMACEUTICALS, INC.: Product Portfolio
13.14.5 REGENERON PHARMACEUTICALS, INC.: Recent Developments
13.15 BioMarin PHARMACEUTICALS, INC.
13.15.1 BioMarin PHARMACEUTICALS, INC.: Company Snapshot
13.15.2 BioMarin PHARMACEUTICALS, INC.: Company Overview
13.15.3 BioMarin PHARMACEUTICALS, INC. Financials, 2015-2019
13.15.4 BioMarin PHARMACEUTICALS, INC.: Product Portfolio
13.15.5 BioMarin PHARMACEUTICALS, INC.: Recent Developments
13.16 Biogen Inc.
13.16.1 Biogen Inc.: Company Snapshot
13.16.2 Biogen Inc.: Company Overview
13.16.3 Biogen Inc. Financials, 2015-2019
13.16.4 Biogen Inc.: Product Portfolio
13.16.5 Biogen Inc.: Recent Developments
13.17 BRISTOL-MYERS SQUIBB
13.17.1 BRISTOL-MYERS SQUIBB: Company Snapshot
13.17.2 BRISTOL-MYERS SQUIBB: Company Overview
13.17.3 BRISTOL-MYERS SQUIBB Financials, 2015-2019
13.17.4 BRISTOL-MYERS SQUIBB: Product Portfolio
13.17.5 BRISTOL-MYERS SQUIBB: Recent Developments
13.18 Biocon
13.18.1 Biocon: Company Snapshot
13.18.2 Biocon: Company Overview
13.18.3 Biocon Financials, 2015-2019
13.18.4 Biocon: Product Portfolio
13.18.5 Biocon: Recent Developments
13.19 Abbvie Inc
13.19.1 Abbvie Inc: Company Snapshot
13.19.2 Abbvie Inc: Company Overview
13.19.3 Abbvie Inc Financials, 2015-2019
13.19.4 Abbvie Inc: Product Portfolio
13.19.5 Abbvie Inc: Recent Developments
13.20 Amgen
13.20.1 Amgen: Company Snapshot
13.20.2 Amgen: Company Overview
13.20.3 Amgen Financials, 2015-2019
13.20.4 Amgen: Product Portfolio
13.20.5 Amgen: Recent Developments
13.21 AstraZeneca PLC
13.21.1 AstraZeneca PLC: Company Snapshot
13.21.2 AstraZeneca PLC: Company Overview
13.21.3 AstraZeneca PLC Financials, 2015-2019
13.21.4 AstraZeneca PLC: Product Portfolio
13.21.5 AstraZeneca PLC: Recent Developments
13.22 Eli Lilly
13.22.1 Eli Lilly: Company Snapshot
13.22.2 Eli Lilly: Company Overview
13.22.3 Eli Lilly Financials, 2015-2019
13.22.4 Eli Lilly: Product Portfolio
13.23 F. Hoffmann-La Roche Ltd
13.23.1 F. Hoffmann-La Roche Ltd: Company Snapshot
13.23.2 F. Hoffmann-La Roche Ltd: Company Overview
13.23.3 F. Hoffmann-La Roche Ltd Financials, 2015-2019
13.23.4 F. Hoffmann-La Roche Ltd: Product Portfolio
13.23.5 F. Hoffmann-La Roche Ltd: Recent Developments
13.24 ANAPTYSBIO, INC.
13.24.1 ANAPTYSBIO, INC.: Company Snapshot
13.24.2 ANAPTYSBIO, INC.: Company Overview
13.24.3 ANAPTYSBIO, INC. Financials, 2015-2019
13.24.4 ANAPTYSBIO, INC.: Product Portfolio
13.24.5 ANAPTYSBIO, INC.: Recent Developments
14 Conclusions
14.1 Leading Products in 2020
14.2 Leading Applications in 2020
14.3 Leading Manufacturing Type in 2020
14.4 Major Revenue Pockets to Look Out For
14.5 Biologics Market to Achieve Steady Growth Throughout the Forecast Period
14.6 Changes in Market Composition: mAbs to Become Leading Submarket
14.7 The Emergence of Biosimilars
14.8 Challenges for the Market
15 Glossary
List of Tables
Table 1 “V” Shaped Recovery: Global Biologics Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 2 “U” Shaped Recovery: Global Biologics Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 3 “W” Shaped Recovery: Global Biologics Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 4 “L” Shaped Recovery: Global Biologics Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 5 Global Biologics Market, 2020-2030 (US$ billion, CAGR %)
Table 6 Global Biologics Market Forecast by Product Type, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 7 Regions of an Antibody
Table 8 Natural Antibody Mechanisms of Action
Table 9 Global Biologics Market for Monoclonal Antibodies Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 10 “V” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 11 “U” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 12 “W” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 13 “L” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 14 Conditions Treated
Table 15 Selected Biosimilar Adalimumab Candidates
Table 16 Global Biologics Market for Humira Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 17 “V” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 18 “U” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 19 “W” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 20 “L” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 21 Global Biologics Market for Remicade Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 22 “V” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 23 “U” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 24 “W” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 25 “L” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 26 Global Biologics Market for Tysabri Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 27 “V” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 28 “U” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 29 “W” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 30 “L” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 31 Global Biologics Market for Avastin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 32 “V” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 33 “U” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 34 “W” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 35 “L” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 36 Global Biologics Market for Herceptin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 37 “V” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 38 “U” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 39 “W” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 40 “L” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 41 Global Biologics Market for Kadcyla Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 42 “V” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 43 “U” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 44 “W” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 45 “L” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 46 Global Biologics Market for Perjeta Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 47 “V” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 48 “U” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 49 “W” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 50 “L” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 51 Global Biologics Market for Opdivo Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 52 “V” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 53 “U” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 54 “W” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 55 “L” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 56 Global Biologics Market for Keytruda Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 57 “V” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 58 “U” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 59 “W” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 60 “L” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 61 FDA-Approved Indications for Cyramza
Table 62 Global Biologics Market for Vaccines Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 63 “V” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 64 “U” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 65 “W” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 66 “L” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 67 Global Biologics Market for Protein Therapeutics Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 68 “V” Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 69 “U” Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 70 “W” Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 71 “L” Shaped Recovery: Global Biologics Systems Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 72 Global Biologics Market for Insulin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 73 “V” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 74 “U” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 75 “W” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 76 “L” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 77 Global Biologics Market for Lantus Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 78 “V” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 79 “U” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 80 “W” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 81 “L” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 82 Global Biologics Market for Novolog Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 83 “V” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 84 “U” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 85 “W” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 86 “L” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 87 Global Biologics Market for Humalog Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 88 “V” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 89 “U” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 90 “W” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 91 “L” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 92 Global Biologics Market for Levemir Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 93 “V” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 94 “U” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 95 “W” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 96 “L” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 97 Global Biologics Market for Apidra Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 98 “V” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 99 “U” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 100 “W” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 101 “L” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 102 Global Biologics Market for Other Recombinant Hormones Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 103 “V” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 104 “U” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 105 “W” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 106 “L” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 107 Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 108 “V” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 109 “U” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 110 “W” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 111 “L” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 112 Global Biologics Market for Interferons Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 113 “V” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 114 “U” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 115 “W” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 116 “L” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 117 Global Biologics Market for Avonex Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 118 “V” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 119 “U” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 120 “W” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 121 “L” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 122 Global Biologics Market for Rebif Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 123 “V” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 124 “U” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 125 “W” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 126 “L” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 127 Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 128 “V” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 129 “U” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 130 “W” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 131 “L” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 132 Global Biologics Market for Regenerative Medicines Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 133 “V” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 134 “U” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 135 “W” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 136 “L” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 137 Potency and Source of Stem Cells
Table 138 Global Biologics Market for Stem Cell Therapy Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 139 “V” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 140 “U” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 141 “W” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 142 “L” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 143 Global Biologics Market for Osteocel Plus Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 144 “V” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 145 “U” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 146 “W” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 147 “L” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 148 Global Biologics Market for Trinity Evolution & Trinity Elite Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 149 “V” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 150 “U” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 151 “W” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 152 “L” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 153 Global Biologics Market for Tissue Engineered Products Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 154 “V” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 155 “U” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 156 “W” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 157 “L” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 158 Global Biologics Market for Apligraft Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 159 “V” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 160 “U” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 161 “W” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 162 “L” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 163 “V” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 164 “U” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 165 “W” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 166 “L” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 167 Global Biologics Market for Dermagraft Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 168 Global Biologics Market for IMIGYLC Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 169 “V” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 170 “U” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 171 “W” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 172 “L” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 173 Global Biologics Market for Fusion Proteins Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 174 “V” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 175 “U” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 176 “W” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 177 “L” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 178 Amgen’s US Patents and Expiry Dates for Enbrel
Table 179 Global Biologics Market for Enbrel Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 180 “V” Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 181 “U” Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 182 “W” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 183 “L” Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 184 Global Biologics Market for Eylea Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 185 “V” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 186 “U” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 187 “W” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 188 “L” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 189 Global Biologics Market Forecast by Application Type, 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 190 Global Biologics Market for Oncology Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 191 “V” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 192 “U” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 193 “W” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 194 “L” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 195 Global Biologics Market for Autoimmune Diseases Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 196 “V” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 197 “U” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 198 “W” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 199 “L” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 200 Global Biologics Market for Infectious Diseases Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 201 “V” Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 202 “U” Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 203 “W” Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 204 “L” Shaped Recovery: Global Biologics Systems Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 205 Global Biologics Market for Cardiovascular Disorders Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 206 “V” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 207 “U” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 208 “W” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 209 “L” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 210 Global Biologics Market for Hematological Disorders Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 211 “V” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 212 “U” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 213 “W” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 214 “L” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 215 Global Biologics Market for Others Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 216 “V” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 217 “U” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 218 “W” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 219 “L” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 220 Global Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 221 Global Biologics Market for Outsourced Manufacturing Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 222 “V” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 223 “U” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 224 “W” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 225 “L” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 226 Global Biologics Market for In-house Manufacturing Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 227 “V” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 228 “U” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 229 “W” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 230 “L” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 231 Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
Table 232 “V” Shaped Recovery: Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
Table 233 “U” Shaped Recovery: Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
Table 234 “W” Shaped Recovery: Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
Table 235 “L” Shaped Recovery: Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
Table 236 North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 237 “V” Shaped Recovery: North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 238 “U” Shaped Recovery: North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 239 “W” Shaped Recovery: North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 240 “L” Shaped Recovery: North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 241 North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 242 “V” Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 243 “U” Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 244 “W” Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 245 “L” Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 246 North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 247 “V” Shaped Recovery: North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 248 “U” Shaped Recovery: North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 249 “W” Shaped Recovery: North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 250 “L” Shaped Recovery: North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 251 U.S. Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 252 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 253 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 254 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 255 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 256 Canada Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 257 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 258 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 259 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 260 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 261 Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 262 “V” Shaped Recovery: Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 263 “U” Shaped Recovery: Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 264 “W” Shaped Recovery: Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 265 “L” Shaped Recovery: Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 266 Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 267 “V” Shaped Recovery: Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 268 “U” Shaped Recovery: Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 269 “W” Shaped Recovery: Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 270 “L” Shaped Recovery: Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 271 Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 272 “V” Shaped Recovery: Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 273 “U” Shaped Recovery: Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 274 “W” Shaped Recovery: Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 275 “L” Shaped Recovery: Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 276 Germany Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 277 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 278 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 279 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 280 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 281 UK Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 282 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 283 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 284 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 285 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 286 France Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 287 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 288 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 289 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 290 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 291 Italy Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 292 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 293 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 294 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 295 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 296 Spain Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 297 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 298 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 299 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 300 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 301 Russia Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 302 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 303 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 304 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 305 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 306 RoE Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 307 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 308 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 309 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 310 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 311 Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 312 “V” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 313 “U” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 314 “W” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 315 “L” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 316 Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 317 “V” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 318 “U” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 319 “W” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 320 “L” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 321 Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 322 “V” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 323 “U” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 324 “W” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 325 “L” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 326 Japan Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 327 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 328 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 329 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 330 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 331 China Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 332 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 333 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 334 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 335 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 336 India Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 337 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 338 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 339 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 340 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 341 Australia Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 342 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 343 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 344 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 345 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 346 RoAP Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 347 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 348 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 349 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 350 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 351 Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 352 “V” Shaped Recovery: Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 353 “U” Shaped Recovery: Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 354 “W” Shaped Recovery: Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 355 “L” Shaped Recovery: Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 356 Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 357 “V” Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 358 “U” Shaped Recovery: Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 359 “W” Shaped Recovery: Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 360 “L” Shaped Recovery: Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 361 Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 362 “V” Shaped Recovery: Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 363 “U” Shaped Recovery: Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 364 “W” Shaped Recovery: Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 365 “L” Shaped Recovery: Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 366 Brazil Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 367 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 368 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 369 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 370 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 371 Mexico Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 372 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 373 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 374 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 375 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 376 RoLA Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 377 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 378 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 379 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 380 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 381 MEA Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 382 “V” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 383 “U” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 384 “W” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 385 “L” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 386 MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 387 “V” Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 388 “U” Shaped Recovery: MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 389 “W” Shaped Recovery: Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 390 “L” Shaped Recovery: MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 391 MEA Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 392 “V” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 393 “U” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 394 “W” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 395 “L” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 396 GCC Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 397 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 398 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 399 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 400 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 401 South Africa Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 402 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 403 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 404 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 405 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 406 RoMEA Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 407 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 408 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 409 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 410 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 411 GlaxoSmithKline Plc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 412 GlaxoSmithKline Plc Product Portfolio
Table 413 GlaxoSmithKline Plc: Recent Developments
Table 414 Johnson & Johnson Services, Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 415 Johnson & Johnson Services, Inc Product Portfolio
Table 416 Johnson & Johnson Services, Inc: Recent Developments
Table 417 Merck & Co Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 418 Merck & Co Product Portfolio
Table 419 Merck & Co: Recent Developments
Table 420 Novartis AG Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 421 Novartis AG Product Portfolio
Table 422 Novartis AG: Recent Developments
Table 423 Pfizer Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 424 Pfizer Inc Product Portfolio
Table 425 Pfizer Inc: Recent Developments
Table 426 Sanofi S.A Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 427 Sanofi S.A Product Portfolio
Table 428 Sanofi S.A: Recent Developments
Table 429 Novo Nordisk A/S Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 430 Novo Nordisk A/S Product Portfolio
Table 431 Novo Nordisk A/S: Recent Developments
Table 432 Takeda Pharmaceutical Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 433 Takeda Pharmaceutical Product Portfolio
Table 434 Takeda Pharmaceutical: Recent Developments
Table 435 Gilead Sciences Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 436 Gilead Sciences Inc Product Portfolio
Table 437 Gilead Sciences Inc: Recent Developments
Table 438 Alexion Pharmaceuticals, Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 439 Alexion Pharmaceuticals, Inc Product Portfolio
Table 440 Alexion Pharmaceuticals, Inc: Recent Developments
Table 441 UCB SA Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 442 UCB SA Product Portfolio
Table 443 UCB SA: Recent Developments
Table 444 Samsung Biologics Co., Ltd Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 445 Samsung Biologics Co., Ltd Product Portfolio
Table 446 Samsung Biologics Co., Ltd: Recent Developments
Table 447 NEKTAR THERAPEUTICS Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 448 NEKTAR THERAPEUTICS Product Portfolio
Table 449 NEKTAR THERAPEUTICS: Recent Developments
Table 450 REGENERON PHARMACEUTICALS, INC. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 451 REGENERON PHARMACEUTICALS, INC. Product Portfolio
Table 452 REGENERON PHARMACEUTICALS, INC.: Recent Developments
Table 453 BioMarin PHARMACEUTICALS, INC. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 454 BioMarin PHARMACEUTICALS, INC.: Recent Developments
Table 455 Biogen Inc. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 456 Biogen Inc. Product Portfolio
Table 457 Biogen Inc.: Recent Developments
Table 458 BRISTOL-MYERS SQUIBB Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 459 BRISTOL-MYERS SQUIBB Product Portfolio
Table 460 BRISTOL-MYERS SQUIBB: Recent Developments
Table 461 Biocon Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 462 Biocon Product Portfolio
Table 463 Biocon: Recent Developments
Table 464 Abbvie Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 465 Abbvie Inc Product Portfolio
Table 466 Abbvie Inc: Recent Developments
Table 467 Amgen Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 468 Amgen Product Portfolio
Table 469 Amgen: Recent Developments
Table 470 AstraZeneca PLC Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 471 AstraZeneca PLC Product Portfolio
Table 472 AstraZeneca PLC: Recent Developments
Table 473 Eli Lilly Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 474 Eli Lilly Product Portfolio
Table 475 F. Hoffmann-La Roche Ltd Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 476 F. Hoffmann-La Roche Ltd Product Portfolio
Table 477 F. Hoffmann-La Roche Ltd: Recent Developments
Table 478 ANAPTYSBIO, INC. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 479 ANAPTYSBIO, INC. Product Portfolio
Table 480 ANAPTYSBIO, INC.: Recent Developments
Table 481 FDA Approved Biosimilars
List of Figures
Figure 1 Global Biologics Market Segmentation
Figure 2 “V” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 3 “U” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 4 “W” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 5 “L” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 6 Global Biologics Market Research Methodology: Top Down & Bottom Up Approach
Figure 7 Global Biologics Market Research Methodology: Data Triangulation
Figure 8 Global Biologics Market Overview
Figure 9 Porter’s Five Forces Analysis
Figure 10 SWOT Analysis
Figure 11 PEST Analysis
Figure 12 Global Biologics Market Forecast by Product Type, 2020-2030 (US$ billion, AGR %)
Figure 13 Global Biologics Market Share Forecast by Product Type, 2020, 2025, 2030 (%)
Figure 14 Global Biologics Market for Monoclonal Antibodies Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 15 “V” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 16 “U” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 17 “W” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 18 “L” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 19 Global Biologics Market for Humira Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 20 “V” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 21 “U” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 22 “W” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 23 “L” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 24 Global Biologics Market for Remicade Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 25 “V” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 26 “U” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 27 “W” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 28 “L” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 29 Global Biologics Market for Tysabri Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 30 “V” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 31 “U” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 32 “W” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 33 “L” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 34 Global Biologics Market for Avastin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 35 “V” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 36 “U” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 37 “W” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 38 “L” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 39 Global Biologics Market for Herceptin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 40 “V” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 41 “U” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 42 “W” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 43 “L” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 44 Global Biologics Market for Kadcyla Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 45 “V” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 46 “U” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 47 “W” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 48 “L” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 49 Global Biologics Market for Perjeta Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 50 “V” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 51 “U” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 52 “W” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 53 “L” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 54 Global Biologics Market for Opdivo Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 55 “V” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 56 “U” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 57 “W” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 58 “L” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 59 Global Biologics Market for Keytruda Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 60 “V” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 61 “U” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 62 “W” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 63 “L” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 64 Global Biologics Market for Vaccines Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 65 “V” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 66 “U” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 67 “W” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 68 “L” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 69 Global Biologics Market for Protein Therapeutics Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 70 “V” Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 71 “U” Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 72 “W” Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 73 “L” Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 74 Global Biologics Market for Insulin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 75 “V” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 76 “U” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 77 “W” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 78 “L” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 79 Global Biologics Market for Lantus Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 80 “V” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 81 “U” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 82 “W” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 83 “L” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 84 Global Biologics Market for Novolog Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 85 “V” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 86 “U” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 87 “W” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 88 “L” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 89 Global Biologics Market for Humalog Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 90 “V” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 91 “U” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 92 “W” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 93 “L” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 94 Global Biologics Market for Levemir Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 95 “V” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 96 “U” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 97 “W” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 98 “L” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 99 Global Biologics Market for Apidra Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 100 “V” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 101 “U” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 102 “W” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 103 “L” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 104 Global Biologics Market for Other Recombinant Hormones Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 105 “V” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 106 “U” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 107 “W” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 108 “L” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 109 Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 110 “V” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 111 “U” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 112 “W” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 113 “L” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 114 Global Biologics Market for Interferons Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 115 “V” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 116 “U” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 117 “W” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 118 “L” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 119 Global Biologics Market for Avonex Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 120 “V” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 121 “U” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 122 “W” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 123 “L” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 124 Global Biologics Market for Rebif Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 125 “V” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 126 “U” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 127 “W” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 128 “L” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 129 Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 130 “V” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 131 “U” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 132 “W” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 133 “L” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 134 Global Biologics Market for Regenerative Medicines Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 135 “V” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 136 “U” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 137 “W” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 138 “L” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 139 Global Biologics Market for Stem Cell Therapy Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 140 “V” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 141 “U” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 142 “W” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 143 “L” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 144 Global Biologics Market for Osteocel Plus Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 145 “V” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 146 “U” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 147 “W” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 148 “L” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 149 Global Biologics Market for Trinity Evolution & Trinity Elite Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 150 “V” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 151 “U” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 152 “W” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 153 “L” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 154 Global Biologics Market for Tissue Engineered Products Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 155 “V” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 156 “U” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 157 “W” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 158 “L” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 159 Global Biologics Market for Apligraft Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 160 “V” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 161 “U” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 162 “W” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 163 “L” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 164 “V” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 165 “U” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 166 “W” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 167 “L” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 168 Global Biologics Market for Dermagraft Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 169 Global Biologics Market for IMIGYLC Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 170 “V” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 171 “U” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 172 “W” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 173 “L” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 174 Global Biologics Market for Fusion Proteins Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 175 “V” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 176 “U” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 177 “W” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 178 “L” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 179 Global Biologics Market for Enbrel Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 180 “V” Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 181 “U” Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 182 “W” Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 183 “L” Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 184 Global Biologics Market for Eylea Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 185 “V” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 186 “U” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 187 “W” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 188 “L” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 189 Global Biologics Market Forecast by Application Type, 2020-2030 (US$ Billion, AGR %)
Figure 190 Global Biologics Market Share Forecast by Application Type, 2020, 2025, 2030 (%)
Figure 191 Global Biologics Market for Oncology Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 192 “V” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 193 “U” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 194 “W” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 195 “L” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 196 Global Biologics Market for Autoimmune Diseases Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 197 “V” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 198 “U” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 199 “W” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 200 “L” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 201 Global Biologics Market for Infectious Diseases Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 202 “V” Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 203 “U” Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 204 “W” Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 205 “L” Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 206 Global Biologics Market for Cardiovascular Disorders Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 207 “V” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 208 “U” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 209 “W” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 210 “L” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 211 Global Biologics Market for Hematological Disorders Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 212 “V” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 213 “U” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 214 “W” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 215 “L” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 216 Global Biologics Market for Others Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 217 “V” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 218 “U” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 219 “W” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 220 “L” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 221 Global Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Figure 222 Global Biologics Market Share Forecast by Manufacturing, 2020, 2025, 2030 (%)
Figure 223 Global Biologics Market for Outsourced Manufacturing Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 224 “V” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 225 “U” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 226 “W” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 227 “L” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 228 Global Biologics Market for In-house Manufacturing Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 229 “V” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 230 “U” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 231 “W” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 232 “L” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 233 Global Biologics Market Forecast by Region 2020-2030 (US$ Billion)
Figure 234 Global Biologics Market Share Forecast by Region 2020, 2025, 2030 (%)
Figure 235 North America Biologics Market Forecast by Country, 2020-2030 (US$ Billion)
Figure 236 North America Biologics Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 237 North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
Figure 238 North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
Figure 239 North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
Figure 240 U.S. Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 241 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 242 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 243 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 244 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 245 Canada Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 246 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 247 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 248 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 249 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 250 Europe Biologics Market Forecast by Country, 2020-2030 (US$ Billion)
Figure 251 Europe Biologics Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 252 Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
Figure 253 Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
Figure 254 Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
Figure 255 Germany Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 256 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 257 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 258 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 259 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 260 UK Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 261 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 262 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 263 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 264 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 265 France Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 266 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 267 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 268 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 269 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 270 Italy Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 271 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 272 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 273 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 274 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 275 Spain Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 276 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 277 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 278 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 279 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 280 Russia Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 281 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 282 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 283 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 284 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 285 RoE Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 286 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 287 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 288 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 289 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 290 Asia-Pacific Biologics Market Forecast by Country, 2020-2030 (US$ Billion)
Figure 291 Asia-Pacific Biologics Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 292 Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
Figure 293 Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
Figure 294 Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
Figure 295 Japan Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 296 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 297 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 298 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 299 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 300 China Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 301 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 302 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 303 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 304 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 305 India Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 306 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 307 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 308 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 309 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 310 Australia Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 311 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 312 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 313 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 314 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 315 RoAP Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 316 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 317 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 318 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 319 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 320 Latin America Biologics Market Forecast by Country, 2020-2030 (US$ Billion)
Figure 321 Latin America Biologics Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 322 Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
Figure 323 Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
Figure 324 Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
Figure 325 Brazil Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 326 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 327 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 328 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 329 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 330 Mexico Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 331 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 332 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 333 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 334 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 335 RoLA Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 336 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 337 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 338 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 339 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 340 MEA Biologics Market Forecast by Country, 2020-2030 (US$ Billion)
Figure 341 MEA Biologics Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 342 MEA Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
Figure 343 MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
Figure 344 MEA Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
Figure 345 GCC Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 346 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 347 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 348 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 349 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 350 South Africa Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 351 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 352 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 353 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 354 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 355 RoMEA Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 356 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 357 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 358 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 359 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 360 Biologics Market for Monoclonal Antibodies: Company Share Analysis (%), 2019
Figure 361 GlaxoSmithKline Plc Financials, 2015-2019 (US$ million, AGR %)
Figure 362 Johnson & Johnson Financials, 2015-2019 (US$ million
Figure 363 Merck & Co Financials, 2015-2019 (US$ million, AGR %)
Figure 364 Novartis AG Financials, 2015-2019 (US$ million, AGR %)
Figure 365 Pfizer Inc Financials, 2015-2019 (US$ million, AGR %)
Figure 366 Sanofi S.A Financials, 2015-2019 (US$ million, AGR %)
Figure 367 Novo Nordisk A/S Financials, 2015-2019 (US$ million, AGR %)
Figure 368 Takeda Pharmaceutical Financials, 2015-2019 (US$ million, AGR %)
Figure 369 Gilead Sciences Inc Financials, 2015-2019 (US$ million, AGR %)
Figure 370 Alexion Pharmaceuticals, Inc Financials, 2015-2019 (US$ million, AGR %)
Figure 371 UCB SA Financials, 2015-2019 (US$ million, AGR %)
Figure 372 Samsung Biologics Co., Ltd Financials, 2015-2019 (US$ million, AGR %)
Figure 373 NEKTAR THERAPEUTICS Financials, 2015-2019 (US$ million, AGR %)
Figure 374 REGENERON PHARMACEUTICALS, INC. Financials, 2015-2019 (US$ million, AGR %)
Figure 375 BioMarin PHARMACEUTICALS, INC. Financials, 2015-2019 (US$ million, AGR %)
Figure 376 Biogen Inc. Financials, 2015-2019 (US$ million, AGR %)
Figure 377 BRISTOL-MYERS SQUIBB Financials, 2015-2019 (US$ Million, AGR %)
Figure 378 Biocon Financials, 2015-2019 (US$ Million, AGR %)
Figure 379 Abbvie Inc Financials, 2015-2019 (US$ million, AGR %)
Figure 380 Amgen Financials, 2015-2019 (US$ million, AGR %)
Figure 381 AstraZeneca PLC Financials, 2015-2019 (US$ million, AGR %)
Figure 382 Eli Lilly Financials, 2015-2019 (US$ million, AGR %)
Figure 383 F. Hoffmann-La Roche Ltd Financials, 2015-2019 (US$ million, AGR %)
Figure 384 ANAPTYSBIO, INC. Financials, 2015-2019 (US$ million, AGR %)
1.1 Introduction to Biologics Market
1.1. Global Biologics Market Segmentation
1.2 Biologics Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.1.1 Impact of COVID 19 on Global Pharma Supply Chain
1.7.1.2 Worldwide air transportation availability and costs
1.7.1.3 Return of pharmaceutical manufacturing back to the US
1.7.1.4 Possible supply disruptions of drugs identified as potential treatments against COVID-19
1.7.1.5 Prescription refills
1.7.1.6 Impact of pharmaceutical companies in clinical need
1.7.1.7 Battle for cure
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Market Size Estimation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Drivers
3.1.1 Ability to command high prices
3.1.2 Aging population and the rise of chronic disease
3.1.3 Product launches will drive biologics market
3.1.4 Rise in prevalence of chronic diseases
3.2 Restraints
3.2.1 Difficulty in manufacturing biologics
3.2.2 Stringent regulatory process and high capital investment
3.2.3 High costs in the face of declining national healthcare budgets
3.3 Opportunities
3.3.1 Application of biologics in complex diseases
3.3.2 Rising demand for next generation biologics
3.3.3 Consolidation growing in the industry
3.3.4 Pleasant policy controls
3.3.5 Strong pipeline of biologics drugs
3.4 Challenges
3.4.1 Risk and damage to supply chain due to COVID-19
3.4.2 Development of promising biological molecule into an effective product
3.4.3 Biosimilars – both an opportunity and a threat
3.5 Trends
3.5.1 Growing strategic partnerships in China
3.5.2 Outsourcing strategies
3.6 Porter’s Five Forces Analysis
3.6.1 Competitive Rivalry - High
3.6.2 Threat of New Entrants - Low
3.6.3 Bargaining Power of Suppliers - Low
3.6.4 Bargaining Power of Buyers - Medium
3.6.5 Threat of Substitutes – Medium/Low
3.7 SWOT Analysis
3.7.1 Strengths
3.7.2 Weaknesses
3.7.3 Opportunities
3.7.4 Threats
3.8 PEST Analysis
3.8.1 Political
3.8.2 Economical
3.8.3 Social
3.8.4 Technological
4 Global Biologics Market Size Forecast 2020-2030 by Product Type
4.1 Global Biologics Market for Monoclonal Antibodies Segment: Revenue Forecast 2020-2030
4.1.1 Monoclonal Antibodies Sub-market: Scientific and Historical Background
4.1.1.1 Natural Antibodies: Key to the Immune System
4.1.1.2 From serum therapy to monoclonal antibodies
4.1.1.3 Humanising the mAb
4.1.1.4 MAbs have found success in treating autoimmune disorders, cancers and other diseases – Great potential for the future
4.1.1.5 MAbs for All? Technologies Come Off Patent
4.1.2 Global Biologics Market for Monoclonal Antibodies Segment: Recovery Forecasts (V,U, W, L)
4.1.3 Autoimmune mAbs
4.1.3.1 Humira – The World’s Best-Selling Prescription Drug
4.1.3.1.1 Expanded Indications for Humira
4.1.3.1.2 Biosimilar Adalimumab: Patents Protect Humira in Developed Markets for Now
4.1.4 Global Biologics Market for Humira Segment: Recovery Forecasts (V,U, W, L)
4.1.4.1 Remicade: A Treatment for Immune-mediated Inflammatory Diseases
4.1.4.1.1 Patent Dance in the US
4.1.4.1.2 Biosimilar Infliximab: Multiple Launches
4.1.5 Global Biologics Market for Remicade Segment: Recovery Forecasts (V,U, W, L)
4.1.5.1 Tysabri: Blockbuster Drug’s High Efficacy Offsets its Risks
4.1.6 Global Biologics Market for Tysabri Segment: Recovery Forecasts (V,U, W, L)
4.1.7 Oncology mAbs
4.1.7.1 Past Approvals
4.1.7.2 Rising Incidence of Cancer Will Drive Demand
4.1.7.3 Rituxan: The World’s Leading Anti-Cancer mAb
4.1.7.4 Biosimilar Rituximab: Two Candidates Await Approval in Europe
4.1.7.5 Avastin: Growing under CER, Through New Indications
4.1.7.5.1 Controversy over Off-Label Avastin use: Roche is Backed up by Incidents in India, and Opinion of EFPIA
4.1.7.5.2 Biosimilar Bevacizumab: Late Patent Expiry is a Blessing for Roche, Although Various Biosimilars in Development
4.1.8 Global Biologics Market for Avastin Segment: Recovery Forecasts (V,U, W, L)
4.1.8.1 Herceptin: Breast Cancer Blockbuster
4.1.8.1.1 Pricing Challenges in Emerging Markets
4.1.8.1.2 Roche Builds Franchise of Anti-HER2 mAbs Around Herceptin
4.1.8.1.3 Biosimilar Trastuzumab
4.1.9 Global Biologics Market for Herceptin Segment: Recovery Forecasts (V,U, W, L)
4.1.9.1 Kadcyla
4.1.9.1.1 Mixed Results from Different Clinical Trials
4.1.9.1.2 Kadcyla Sales Forecast 2020 -2030
4.1.10 Global Biologics Market for Kadcyla Segment: Recovery Forecasts (V,U, W, L)
4.1.10.1 Perjeta
4.1.10.1.1 Positive Results from Different Clinical Trials
4.1.11 Global Biologics Market for Perjeta Segment: Recovery Forecasts (V,U, W, L)
4.1.11.1 Opdivo: Big Potential for Bristol-Myer Squibb’s PD-1 Inhibitor
4.1.12 Global Biologics Market for Opdivo Segment: Recovery Forecasts (V,U, W, L)
4.1.12.1 Keytruda
4.1.13 Global Biologics Market for Keytruda Segment: Recovery Forecasts (V,U, W, L)
4.1.13.1.1 Good News and Bad News for NSCLC from CheckMate Trials
4.1.13.1.2 Cyramza (Eli Lilly): Approved in Three Additional Indications Since its First Approval in April 2014.
4.1.13.2 Oncology mAbs: New Approvals and Pipeline
4.1.13.2.1 Empliciti (Elotuzumab) by Bristol-Myers Squibb and AbbVie): Recently Approved
4.1.13.2.2 Unituxin (United Therapeutics) Receives FDA Approval March 2015
4.1.13.2.3 SAR3419 (coltuximab ravtansine) (anti-CD19, Sanofi)
4.2 Global Biologics Market for Vaccines Segment: Revenue Forecast 2020-2030
4.2.1 Global Biologics Market for Vaccines Segment: Recovery Forecasts (V,U, W, L)
4.3 Global Biologics Market for Protein Therapeutics Segment: Revenue Forecast 2020-2030
4.3.1 Global Biologics Market for Protein Therapeutics Segment: Recovery Forecasts (V,U, W, L)
4.3.2 Global Biologics Market for Insulin Sub Segment: Revenue Forecast 2020-2030
4.3.3 Global Biologics Market for Insulin Segment: Recovery Forecasts (V,U, W, L)
4.3.3.1 Lantus
4.3.4 Global Biologics Market for Lantus Segment: Recovery Forecasts (V,U, W, L)
4.3.4.1 NovoLog/NovoRapid
4.3.5 Global Biologics Market for Novolog Segment: Recovery Forecasts (V,U, W, L)
4.3.5.1 Humalog
4.3.6 Global Biologics Market for Humalog Segment: Recovery Forecasts (V,U, W, L)
4.3.6.1 Levemir
4.3.7 Global Biologics Market for Levemir Segment: Recovery Forecasts (V,U, W, L)
4.3.7.1 Apidra
4.3.8 Global Biologics Market for Apidra Segment: Recovery Forecasts (V,U, W, L)
4.3.9 Other Recombinant Hormones: Erythropoietins, G-CSF and Human Growth Hormone
4.3.10 Global Biologics Market for Other Recombinant Hormones Segment: Recovery Forecasts (V,U, W, L)
4.3.10.1 Erythropoietin
4.3.10.2 G-CSF
4.3.10.3 Human Growth Hormones
4.3.10.4 Plasma and Recombinant Coagulating Factors
4.3.11 Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment: Recovery Forecasts (V,U, W, L)
4.3.11.1 Interferons
4.3.12 Global Biologics Market for Interferons Segment: Recovery Forecasts (V,U, W, L)
4.3.12.1.1 Avonex
4.3.13 Global Biologics Market for Avonex Segment: Recovery Forecasts (V,U, W, L)
4.3.13.1.1 Rebif
4.3.14 Global Biologics Market for Rebif Segment: Recovery Forecasts (V,U, W, L)
4.3.14.1.1 Betaseron
4.3.14.1.2 Plegridy
4.3.14.2 Enzyme Replacement and Other Protein Therapies
4.3.15 Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment: Recovery Forecasts (V,U, W, L)
4.4 Global Biologics Market for Regenerative Medicines Segment: Revenue Forecast 2020-2030
4.4.1 Global Biologics Market for Regenerative Medicines Segment: Recovery Forecasts (V,U, W, L)
4.4.2 Stem Cell Therapies
4.4.2.1 Stem Cells: Scientific Breakdown
4.4.3 Stem Cell Therapies
4.4.3.1 Haematopoietic Stem Cell Transplantation:
4.4.3.2 From Procedures to Products: Cord Blood Stem Cell Approvals
4.4.4 Global Biologics Market for Stem Cell Therapy Segment: Recovery Forecasts (V,U, W, L)
4.4.4.1 Osteocel Plus: The Leading Stem Cell Orthobiologic
4.4.5 Global Biologics Market for Osteocel Plus Segment: Recovery Forecasts (V,U, W, L)
4.4.5.1 Trinity Evolution and Trinity Elite
4.4.5.1.1 Trinity Evolution and Trinity Elite Revenue Forecast to 2030
4.4.6 Global Biologics Market for Trinity Evolution & Trinity Elite Segment: Recovery Forecasts (V,U, W, L)
4.4.6.1.1 MSC-100-IV (Previously Known as Prochymal): World’s First Approved Stem Cell Drug Outside of South Korea
4.4.6.1.2 An Important Role to Play in the Future of HSCT, and also Wins Approval in Japan through Partner
4.4.6.1.3 CARTISTEM (MEDIPOST): The World’s First Allogeneic Stem Cell Drug
4.4.6.1.4 Hearticellgram-AMI (PharmaCell B.V.): One of the First Approved Cardiovascular Stem Cell Treatments in the World.
4.4.7 Tissue Engineering Therapies
4.4.7.1 Tissue Engineering – In Vitro Manipulation for Therapeutic Purposes
4.4.7.2 Current Status of the Market
4.4.8 Global Biologics Market for Tissue Engineered Products Segment: Recovery Forecasts (V,U, W, L)
4.4.8.1 Apligraf: The Leading Product
4.4.8.2 Apligraf’s role in Wound Healing
4.4.9 Global Biologics Market for Dermagraft Segment: Recovery Forecasts (V,U, W, L)
4.4.9.1 ReCell
4.4.9.2 MySkin and CyroSkin
4.4.10 Global Biologics Market for Apligraft Segment: Recovery Forecasts (V,U, W, L)
4.4.10.1 Dermagraft: Organogenesis Further Strengthens Position Through this 2014 Acquisition
4.4.11 Tissue Engineering Therapies Pipeline
4.4.11.1 NeoCart by Histogenics: Undergoing Phase 3 Trial for Knee Cartilage Repair
4.4.11.2 Extracorporeal Bio-Artificial Liver Therapy by Vital Therapies
4.4.11.3 StrataGraft by Stratatech Corporation Demonstrates Positive Top-Line Results
4.4.12 Gene Therapies
4.4.12.1 Gene Therapy: Historical and Scientific Background
4.4.12.2 Harnessing Infectivity: Viral Vectors in Gene Therapy
4.4.12.3 Approved Gene Therapy Products
4.4.12.3.1 Gendicine: The World’s First Commercial Gene Therapy Product
4.4.12.3.2 Oncorine: First Oncolytic Viral Therapy
4.4.12.3.3 Neovasculgen: Russia’s First Gene Therapy
4.4.12.3.4 Neovasculgen: Drop in Revenues in 2015, but HSCI Predicts Notable Increases as Product is Added to VED List
4.4.12.3.5 Glybera: The First Gene Therapy for Western Markets, Although Has Abandoned Hope of Receiving FDA-Approval
4.4.12.4 IMLYGIC
4.4.12.4.1 IMLYGIC: Clinical Trials and Development Efforts
4.4.13 Global Biologics Market for IMIGYLC Segment: Recovery Forecasts (V,U, W, L)
4.5 Global Biologics Market for Fusion Proteins Segment: Revenue Forecast 2020-2030
4.5.1 Scientific and Historical Background
4.5.1.1 Differentiating Fusion Proteins
4.5.2 Global Biologics Market for Fusion Proteins Segment: Recovery Forecasts (V,U, W, L)
4.5.3 Enbrel: The First FP to be Approved, in 1998
4.5.3.1 Gradually Approved for Additional Indications
4.5.3.2 Enbrel Granted Extended Patent Protection in the US, Patent has Expired in EU
4.5.3.3 Multiple Biosimilars Available in Emerging Markets
4.5.4 Global Biologics Market for Enbrel Segment: Recovery Forecasts (V,U, W, L)
4.5.5 Eylea: Blockbuster FP Treatment for Wet AMD
4.5.6 Global Biologics Market for Eylea Segment: Recovery Forecasts (V,U, W, L)
4.5.7 Fusion Proteins Pipeline
4.5.7.1 Sotatercept by Acceleron Pharma and Celgene Corporation - Currently Undergoing Eight Clinical Trials
4.5.7.2 Blisibimod (Anthera Pharmaceuticals) for the Treatment of Various Autoimmune Diseases, in Late Stage Development
5 Global Biologics Market Size Forecast 2020-2030 by Application Type
5.1 Global Biologics Market for Oncology Segment: Revenue Forecast 2020-2030
5.1.1 Global Biologics Market for Oncology Segment: Recovery Forecasts (V,U, W, L)
5.2 Global Biologics Market for Autoimmune Diseases Segment: Revenue Forecast 2020-2030
5.2.1 Global Biologics Market for Autoimmune Diseases Segment: Recovery Forecasts (V,U, W, L)
5.3 Global Biologics Market for Infectious Diseases Segment: Revenue Forecast 2020-2030
5.3.1 Global Biologics Market for Infectious Diseases Segment: Recovery Forecasts (V,U, W, L)
5.4 Global Biologics Market for Cardiovascular Disorders Segment: Revenue Forecast 2020-2030
5.4.1 Global Biologics Market for Cardiovascular Disorders Segment: Recovery Forecasts (V,U, W, L)
5.5 Global Biologics Market for Hematological Disorders Segment: Revenue Forecast 2020-2030
5.5.1 Global Biologics Market for Hematological Disorders Segment: Recovery Forecasts (V,U, W, L)
5.6 Global Biologics Market for Others Segment: Revenue Forecast 2020-2030
5.6.1 Global Biologics Market for Others Segment: Recovery Forecasts (V,U, W, L)
6 Global Biologics Market Size Forecast 2020-2030 by Manufacturing
6.1 Global Biologics Market for Outsourced Manufacturing Segment: Revenue Forecast 2020-2030
6.1.1 Global Biologics Market for Outsourced Manufacturing Segment: Recovery Forecasts (V,U, W, L)
6.2 Global Biologics Market for In-house Manufacturing Segment: Revenue Forecast 2020-2030
6.2.1 Global Biologics Market for In-house Manufacturing Segment: Recovery Forecasts (V,U, W, L)
7 Regional and Leading National Biologics Market Forecasts 2020-2030
7.1 Global Biologics Market by National Market Forecast 2020-2030
7.1.1 Global Biologics Market Forecast 2020-2030, Recovery Scenarios
8 North America
8.1 North America Biologics Market Forecast by Country, 2020-2030
8.2 North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
8.2.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
8.3 North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
8.3.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
8.4 North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
8.4.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
8.5 U.S. Biologics Market Forecast 2020-2030
8.5.1 U.S. Biologics Market: Recovery Scenarios
8.6 Canada Biologics Market Forecast 2020-2030
8.6.1 Canada Biologics Market: Recovery Scenarios
9 Europe
9.1 Europe Biologics Market Forecast by Country, 2020-2030
9.2 Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
9.2.1 Recovery Scenarios (V, U, W, L) Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
9.3 Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
9.3.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
9.4 Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
9.4.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
9.5 Germany Biologics Market Forecast 2020-2030
9.5.1 Germany Biologics Market: Recovery Scenarios
9.6 UK Biologics Market Forecast 2020-2030
9.6.1 UK Biologics Market: Recovery Scenarios
9.7 France Biologics Market Forecast 2020-2030
9.7.1 France Biologics Market: Recovery Scenarios
9.8 Italy Biologics Market Forecast 2020-2030
9.8.1 Italy Biologics Market: Recovery Scenarios
9.9 Spain Biologics Market Forecast 2020-2030
9.9.1 Spain Biologics Market: Recovery Scenarios
9.10 Russia Biologics Market Forecast 2020-2030
9.10.1 Russia Biologics Market: Recovery Scenarios
9.11 RoE Biologics Market Forecast 2020-2030
9.11.1 RoE Biologics Market: Recovery Scenarios
10 Asia-Pacific
10.1 Asia-Pacific Biologics Market Forecast by Country, 2020-2030
10.2 Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
10.2.1 Recovery Scenarios (V, U, W, L): Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
10.3 Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
10.3.1 Recovery Scenarios (V, U, W, L): Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
10.4 Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
10.4.1 Recovery Scenarios (V, U, W, L): Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
10.5 Japan Biologics Market Forecast 2020-2030
10.5.1 Japan Biologics Market: Recovery Scenarios
10.6 China Biologics Market Forecast 2020-2030
10.6.1 China Biologics Market: Recovery Scenarios
10.7 India Biologics Market Forecast 2020-2030
10.7.1 India Biologics Market: Recovery Scenarios
10.8 Australia Biologics Market Forecast 2020-2030
10.8.1 Australia Biologics Market: Recovery Scenarios
10.9 RoAP Biologics Market Forecast 2020-2030
10.9.1 RoAP Biologics Market: Recovery Scenarios
11 Latin America
11.1 Latin America Biologics Market Forecast by Country, 2020-2030
11.2 Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
11.2.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
11.3 Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
11.3.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
11.4 Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
11.4.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
11.5 Brazil Biologics Market Forecast 2020-2030
11.5.1 Brazil Biologics Market: Recovery Scenarios
11.6 Mexico Biologics Market Forecast 2020-2030
11.6.1 Mexico Biologics Market: Recovery Scenarios
11.7 RoLA Biologics Market Forecast 2020-2030
11.7.1 RoLA Biologics Market: Recovery Scenarios
12 Middle East and Africa
12.1 MEA Biologics Market Forecast by Country, 2020-2030
12.2 MEA Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
12.2.1 Recovery Scenarios (V, U, W, L): Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
12.3 MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
12.3.1 Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
12.4 MEA Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
12.4.1 Recovery Scenarios (V, U, W, L): Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
12.5 GCC Biologics Market Forecast 2020-2030
12.5.1 GCC Biologics Market: Recovery Scenarios
12.6 South Africa Biologics Market Forecast 2020-2030
12.6.1 South Africa Biologics Market: Recovery Scenarios
12.7 RoMEA Biologics Market Forecast 2020-2030
12.7.1 RoMEA Biologics Market: Recovery Scenarios
13 Leading Companies in the Biologics Market
13.1 GlaxoSmithKline Plc
13.1.1 GlaxoSmithKline Plc: Company Snapshot
13.1.2 GlaxoSmithKline Plc: Company Overview
13.1.3 GlaxoSmithKline Plc Financials, 2015-2019
13.1.4 GlaxoSmithKline Plc: Product Portfolio
13.1.5 GlaxoSmithKline Plc: Recent Developments
13.2 Johnson & Johnson Services, Inc
13.2.1 Johnson & Johnson Services, Inc: Company Snapshot
13.2.2 Johnson & Johnson Services, Inc: Company Overview
13.2.3 Johnson & Johnson Services, Inc Financials, 2015-2019
13.2.4 Johnson & Johnson Services, Inc: Product Portfolio
13.2.5 Johnson & Johnson Services, Inc: Recent Developments
13.3 Merck & Co
13.3.1 Merck & Co: Company Snapshot
13.3.2 Merck & Co: Company Overview
13.3.3 Merck & Co Financials, 2015-2019
13.3.4 Merck & Co: Product Portfolio
13.3.5 Merck & Co: Recent Developments
13.4 Novartis AG
13.4.1 Novartis AG: Company Snapshot
13.4.2 Novartis AG: Company Overview
13.4.3 Novartis AG Financials, 2015-2019
13.4.4 Novartis AG: Product Portfolio
13.4.5 Novartis AG: Recent Developments
13.5 Pfizer Inc
13.5.1 Pfizer Inc: Company Snapshot
13.5.2 Pfizer Inc: Company Overview
13.5.3 Pfizer Inc Financials, 2015-2019
13.5.4 Pfizer Inc: Product Portfolio
13.5.5 Pfizer Inc: Recent Developments
13.6 Sanofi S.A
13.6.1 Sanofi S.A: Company Snapshot
13.6.2 Sanofi S.A: Company Overview
13.6.3 Sanofi S.A Financials, 2015-2019
13.6.4 Sanofi S.A: Product Portfolio
13.6.5 Sanofi S.A: Recent Developments
13.7 Novo Nordisk A/S
13.7.1 Novo Nordisk A/S: Company Snapshot
13.7.2 Novo Nordisk A/S: Company Overview
13.7.3 Novo Nordisk A/S Financials, 2015-2019
13.7.4 Novo Nordisk A/S: Product Portfolio
13.7.5 Novo Nordisk A/S: Recent Developments
13.8 Takeda Pharmaceutical
13.8.1 Takeda Pharmaceutical: Company Snapshot
13.8.2 Takeda Pharmaceutical: Company Overview
13.8.3 Takeda Pharmaceutical Financials, 2015-2019
13.8.4 Takeda Pharmaceutical: Product Portfolio
13.8.5 Takeda Pharmaceutical: Recent Developments
13.9 Gilead Sciences Inc
13.9.1 Gilead Sciences Inc: Company Snapshot
13.9.2 Gilead Sciences Inc: Company Overview
13.9.3 Gilead Sciences Inc Financials, 2015-2019
13.9.4 Gilead Sciences Inc: Product Portfolio
13.9.5 Gilead Sciences Inc: Recent Developments
13.10 Alexion Pharmaceuticals, Inc
13.10.1 Alexion Pharmaceuticals, Inc: Company Snapshot
13.10.2 Alexion Pharmaceuticals, Inc: Company Overview
13.10.3 Alexion Pharmaceuticals, Inc Financials, 2015-2019
13.10.4 Alexion Pharmaceuticals, Inc: Product Portfolio
13.10.5 Alexion Pharmaceuticals, Inc: Recent Developments
13.11 UCB SA
13.11.1 UCB SA: Company Snapshot
13.11.2 UCB SA: Company Overview
13.11.3 UCB SA Financials, 2015-2019
13.11.4 UCB SA: Product Portfolio
13.11.5 UCB SA: Recent Developments
13.12 Samsung Biologics Co., Ltd
13.12.1 Samsung Biologics Co., Ltd: Company Snapshot
13.12.2 Samsung Biologics Co., Ltd: Company Overview
13.12.3 Samsung Biologics Co., Ltd Financials, 2015-2019
13.12.4 Samsung Biologics Co., Ltd: Product Portfolio
13.12.5 Samsung Biologics Co., Ltd: Recent Developments
13.13 NEKTAR THERAPEUTICS
13.13.1 NEKTAR THERAPEUTICS: Company Snapshot
13.13.2 NEKTAR THERAPEUTICS: Company Overview
13.13.3 NEKTAR THERAPEUTICS Inc. Financials, 2015-2019
13.13.4 NEKTAR THERAPEUTICS: Product Portfolio
13.13.5 NEKTAR THERAPEUTICS: Recent Developments
13.14 REGENERON PHARMACEUTICALS, INC.
13.14.1 REGENERON PHARMACEUTICALS, INC.: Company Snapshot
13.14.2 REGENERON PHARMACEUTICALS, INC.: Company Overview
13.14.3 REGENERON PHARMACEUTICALS, INC. Financials, 2015-2019
13.14.4 REGENERON PHARMACEUTICALS, INC.: Product Portfolio
13.14.5 REGENERON PHARMACEUTICALS, INC.: Recent Developments
13.15 BioMarin PHARMACEUTICALS, INC.
13.15.1 BioMarin PHARMACEUTICALS, INC.: Company Snapshot
13.15.2 BioMarin PHARMACEUTICALS, INC.: Company Overview
13.15.3 BioMarin PHARMACEUTICALS, INC. Financials, 2015-2019
13.15.4 BioMarin PHARMACEUTICALS, INC.: Product Portfolio
13.15.5 BioMarin PHARMACEUTICALS, INC.: Recent Developments
13.16 Biogen Inc.
13.16.1 Biogen Inc.: Company Snapshot
13.16.2 Biogen Inc.: Company Overview
13.16.3 Biogen Inc. Financials, 2015-2019
13.16.4 Biogen Inc.: Product Portfolio
13.16.5 Biogen Inc.: Recent Developments
13.17 BRISTOL-MYERS SQUIBB
13.17.1 BRISTOL-MYERS SQUIBB: Company Snapshot
13.17.2 BRISTOL-MYERS SQUIBB: Company Overview
13.17.3 BRISTOL-MYERS SQUIBB Financials, 2015-2019
13.17.4 BRISTOL-MYERS SQUIBB: Product Portfolio
13.17.5 BRISTOL-MYERS SQUIBB: Recent Developments
13.18 Biocon
13.18.1 Biocon: Company Snapshot
13.18.2 Biocon: Company Overview
13.18.3 Biocon Financials, 2015-2019
13.18.4 Biocon: Product Portfolio
13.18.5 Biocon: Recent Developments
13.19 Abbvie Inc
13.19.1 Abbvie Inc: Company Snapshot
13.19.2 Abbvie Inc: Company Overview
13.19.3 Abbvie Inc Financials, 2015-2019
13.19.4 Abbvie Inc: Product Portfolio
13.19.5 Abbvie Inc: Recent Developments
13.20 Amgen
13.20.1 Amgen: Company Snapshot
13.20.2 Amgen: Company Overview
13.20.3 Amgen Financials, 2015-2019
13.20.4 Amgen: Product Portfolio
13.20.5 Amgen: Recent Developments
13.21 AstraZeneca PLC
13.21.1 AstraZeneca PLC: Company Snapshot
13.21.2 AstraZeneca PLC: Company Overview
13.21.3 AstraZeneca PLC Financials, 2015-2019
13.21.4 AstraZeneca PLC: Product Portfolio
13.21.5 AstraZeneca PLC: Recent Developments
13.22 Eli Lilly
13.22.1 Eli Lilly: Company Snapshot
13.22.2 Eli Lilly: Company Overview
13.22.3 Eli Lilly Financials, 2015-2019
13.22.4 Eli Lilly: Product Portfolio
13.23 F. Hoffmann-La Roche Ltd
13.23.1 F. Hoffmann-La Roche Ltd: Company Snapshot
13.23.2 F. Hoffmann-La Roche Ltd: Company Overview
13.23.3 F. Hoffmann-La Roche Ltd Financials, 2015-2019
13.23.4 F. Hoffmann-La Roche Ltd: Product Portfolio
13.23.5 F. Hoffmann-La Roche Ltd: Recent Developments
13.24 ANAPTYSBIO, INC.
13.24.1 ANAPTYSBIO, INC.: Company Snapshot
13.24.2 ANAPTYSBIO, INC.: Company Overview
13.24.3 ANAPTYSBIO, INC. Financials, 2015-2019
13.24.4 ANAPTYSBIO, INC.: Product Portfolio
13.24.5 ANAPTYSBIO, INC.: Recent Developments
14 Conclusions
14.1 Leading Products in 2020
14.2 Leading Applications in 2020
14.3 Leading Manufacturing Type in 2020
14.4 Major Revenue Pockets to Look Out For
14.5 Biologics Market to Achieve Steady Growth Throughout the Forecast Period
14.6 Changes in Market Composition: mAbs to Become Leading Submarket
14.7 The Emergence of Biosimilars
14.8 Challenges for the Market
15 Glossary
List of Tables
Table 1 “V” Shaped Recovery: Global Biologics Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 2 “U” Shaped Recovery: Global Biologics Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 3 “W” Shaped Recovery: Global Biologics Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 4 “L” Shaped Recovery: Global Biologics Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 5 Global Biologics Market, 2020-2030 (US$ billion, CAGR %)
Table 6 Global Biologics Market Forecast by Product Type, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 7 Regions of an Antibody
Table 8 Natural Antibody Mechanisms of Action
Table 9 Global Biologics Market for Monoclonal Antibodies Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 10 “V” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 11 “U” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 12 “W” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 13 “L” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 14 Conditions Treated
Table 15 Selected Biosimilar Adalimumab Candidates
Table 16 Global Biologics Market for Humira Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 17 “V” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 18 “U” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 19 “W” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 20 “L” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 21 Global Biologics Market for Remicade Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 22 “V” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 23 “U” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 24 “W” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 25 “L” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 26 Global Biologics Market for Tysabri Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 27 “V” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 28 “U” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 29 “W” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 30 “L” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 31 Global Biologics Market for Avastin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 32 “V” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 33 “U” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 34 “W” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 35 “L” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 36 Global Biologics Market for Herceptin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 37 “V” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 38 “U” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 39 “W” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 40 “L” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 41 Global Biologics Market for Kadcyla Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 42 “V” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 43 “U” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 44 “W” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 45 “L” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 46 Global Biologics Market for Perjeta Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 47 “V” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 48 “U” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 49 “W” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 50 “L” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 51 Global Biologics Market for Opdivo Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 52 “V” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 53 “U” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 54 “W” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 55 “L” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 56 Global Biologics Market for Keytruda Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 57 “V” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 58 “U” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 59 “W” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 60 “L” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 61 FDA-Approved Indications for Cyramza
Table 62 Global Biologics Market for Vaccines Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 63 “V” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 64 “U” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 65 “W” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 66 “L” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 67 Global Biologics Market for Protein Therapeutics Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 68 “V” Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 69 “U” Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 70 “W” Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 71 “L” Shaped Recovery: Global Biologics Systems Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 72 Global Biologics Market for Insulin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 73 “V” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 74 “U” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 75 “W” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 76 “L” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 77 Global Biologics Market for Lantus Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 78 “V” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 79 “U” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 80 “W” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 81 “L” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 82 Global Biologics Market for Novolog Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 83 “V” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 84 “U” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 85 “W” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 86 “L” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 87 Global Biologics Market for Humalog Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 88 “V” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 89 “U” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 90 “W” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 91 “L” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 92 Global Biologics Market for Levemir Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 93 “V” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 94 “U” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 95 “W” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 96 “L” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 97 Global Biologics Market for Apidra Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 98 “V” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 99 “U” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 100 “W” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 101 “L” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 102 Global Biologics Market for Other Recombinant Hormones Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 103 “V” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 104 “U” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 105 “W” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 106 “L” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 107 Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 108 “V” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 109 “U” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 110 “W” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 111 “L” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 112 Global Biologics Market for Interferons Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 113 “V” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 114 “U” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 115 “W” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 116 “L” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 117 Global Biologics Market for Avonex Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 118 “V” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 119 “U” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 120 “W” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 121 “L” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 122 Global Biologics Market for Rebif Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 123 “V” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 124 “U” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 125 “W” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 126 “L” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 127 Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 128 “V” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 129 “U” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 130 “W” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 131 “L” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 132 Global Biologics Market for Regenerative Medicines Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 133 “V” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 134 “U” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 135 “W” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 136 “L” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 137 Potency and Source of Stem Cells
Table 138 Global Biologics Market for Stem Cell Therapy Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 139 “V” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 140 “U” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 141 “W” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 142 “L” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 143 Global Biologics Market for Osteocel Plus Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 144 “V” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 145 “U” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 146 “W” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 147 “L” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 148 Global Biologics Market for Trinity Evolution & Trinity Elite Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 149 “V” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 150 “U” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 151 “W” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 152 “L” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 153 Global Biologics Market for Tissue Engineered Products Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 154 “V” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 155 “U” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 156 “W” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 157 “L” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 158 Global Biologics Market for Apligraft Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 159 “V” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 160 “U” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 161 “W” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 162 “L” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 163 “V” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 164 “U” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 165 “W” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 166 “L” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 167 Global Biologics Market for Dermagraft Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 168 Global Biologics Market for IMIGYLC Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 169 “V” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 170 “U” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 171 “W” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 172 “L” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 173 Global Biologics Market for Fusion Proteins Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 174 “V” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 175 “U” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 176 “W” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 177 “L” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 178 Amgen’s US Patents and Expiry Dates for Enbrel
Table 179 Global Biologics Market for Enbrel Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 180 “V” Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 181 “U” Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 182 “W” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 183 “L” Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 184 Global Biologics Market for Eylea Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 185 “V” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 186 “U” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 187 “W” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 188 “L” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 189 Global Biologics Market Forecast by Application Type, 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 190 Global Biologics Market for Oncology Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 191 “V” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 192 “U” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 193 “W” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 194 “L” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 195 Global Biologics Market for Autoimmune Diseases Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 196 “V” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 197 “U” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 198 “W” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 199 “L” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 200 Global Biologics Market for Infectious Diseases Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 201 “V” Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 202 “U” Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 203 “W” Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 204 “L” Shaped Recovery: Global Biologics Systems Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 205 Global Biologics Market for Cardiovascular Disorders Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 206 “V” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 207 “U” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 208 “W” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 209 “L” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 210 Global Biologics Market for Hematological Disorders Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 211 “V” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 212 “U” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 213 “W” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 214 “L” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 215 Global Biologics Market for Others Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 216 “V” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 217 “U” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 218 “W” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 219 “L” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 220 Global Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 221 Global Biologics Market for Outsourced Manufacturing Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 222 “V” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 223 “U” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 224 “W” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 225 “L” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 226 Global Biologics Market for In-house Manufacturing Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 227 “V” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 228 “U” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 229 “W” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 230 “L” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 231 Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
Table 232 “V” Shaped Recovery: Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
Table 233 “U” Shaped Recovery: Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
Table 234 “W” Shaped Recovery: Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
Table 235 “L” Shaped Recovery: Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
Table 236 North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 237 “V” Shaped Recovery: North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 238 “U” Shaped Recovery: North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 239 “W” Shaped Recovery: North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 240 “L” Shaped Recovery: North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 241 North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 242 “V” Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 243 “U” Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 244 “W” Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 245 “L” Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 246 North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 247 “V” Shaped Recovery: North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 248 “U” Shaped Recovery: North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 249 “W” Shaped Recovery: North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 250 “L” Shaped Recovery: North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 251 U.S. Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 252 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 253 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 254 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 255 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 256 Canada Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 257 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 258 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 259 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 260 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 261 Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 262 “V” Shaped Recovery: Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 263 “U” Shaped Recovery: Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 264 “W” Shaped Recovery: Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 265 “L” Shaped Recovery: Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 266 Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 267 “V” Shaped Recovery: Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 268 “U” Shaped Recovery: Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 269 “W” Shaped Recovery: Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 270 “L” Shaped Recovery: Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 271 Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 272 “V” Shaped Recovery: Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 273 “U” Shaped Recovery: Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 274 “W” Shaped Recovery: Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 275 “L” Shaped Recovery: Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 276 Germany Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 277 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 278 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 279 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 280 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 281 UK Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 282 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 283 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 284 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 285 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 286 France Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 287 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 288 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 289 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 290 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 291 Italy Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 292 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 293 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 294 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 295 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 296 Spain Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 297 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 298 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 299 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 300 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 301 Russia Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 302 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 303 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 304 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 305 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 306 RoE Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 307 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 308 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 309 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 310 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 311 Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 312 “V” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 313 “U” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 314 “W” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 315 “L” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 316 Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 317 “V” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 318 “U” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 319 “W” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 320 “L” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 321 Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 322 “V” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 323 “U” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 324 “W” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 325 “L” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 326 Japan Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 327 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 328 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 329 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 330 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 331 China Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 332 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 333 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 334 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 335 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 336 India Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 337 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 338 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 339 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 340 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 341 Australia Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 342 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 343 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 344 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 345 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 346 RoAP Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 347 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 348 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 349 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 350 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 351 Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 352 “V” Shaped Recovery: Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 353 “U” Shaped Recovery: Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 354 “W” Shaped Recovery: Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 355 “L” Shaped Recovery: Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 356 Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 357 “V” Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 358 “U” Shaped Recovery: Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 359 “W” Shaped Recovery: Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 360 “L” Shaped Recovery: Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 361 Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 362 “V” Shaped Recovery: Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 363 “U” Shaped Recovery: Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 364 “W” Shaped Recovery: Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 365 “L” Shaped Recovery: Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 366 Brazil Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 367 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 368 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 369 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 370 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 371 Mexico Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 372 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 373 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 374 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 375 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 376 RoLA Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 377 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 378 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 379 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 380 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 381 MEA Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 382 “V” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 383 “U” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 384 “W” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 385 “L” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 386 MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 387 “V” Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 388 “U” Shaped Recovery: MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 389 “W” Shaped Recovery: Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 390 “L” Shaped Recovery: MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 391 MEA Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 392 “V” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 393 “U” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 394 “W” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 395 “L” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 396 GCC Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 397 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 398 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 399 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 400 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 401 South Africa Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 402 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 403 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 404 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 405 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 406 RoMEA Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 407 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 408 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 409 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 410 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 411 GlaxoSmithKline Plc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 412 GlaxoSmithKline Plc Product Portfolio
Table 413 GlaxoSmithKline Plc: Recent Developments
Table 414 Johnson & Johnson Services, Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 415 Johnson & Johnson Services, Inc Product Portfolio
Table 416 Johnson & Johnson Services, Inc: Recent Developments
Table 417 Merck & Co Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 418 Merck & Co Product Portfolio
Table 419 Merck & Co: Recent Developments
Table 420 Novartis AG Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 421 Novartis AG Product Portfolio
Table 422 Novartis AG: Recent Developments
Table 423 Pfizer Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 424 Pfizer Inc Product Portfolio
Table 425 Pfizer Inc: Recent Developments
Table 426 Sanofi S.A Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 427 Sanofi S.A Product Portfolio
Table 428 Sanofi S.A: Recent Developments
Table 429 Novo Nordisk A/S Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 430 Novo Nordisk A/S Product Portfolio
Table 431 Novo Nordisk A/S: Recent Developments
Table 432 Takeda Pharmaceutical Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 433 Takeda Pharmaceutical Product Portfolio
Table 434 Takeda Pharmaceutical: Recent Developments
Table 435 Gilead Sciences Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 436 Gilead Sciences Inc Product Portfolio
Table 437 Gilead Sciences Inc: Recent Developments
Table 438 Alexion Pharmaceuticals, Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 439 Alexion Pharmaceuticals, Inc Product Portfolio
Table 440 Alexion Pharmaceuticals, Inc: Recent Developments
Table 441 UCB SA Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 442 UCB SA Product Portfolio
Table 443 UCB SA: Recent Developments
Table 444 Samsung Biologics Co., Ltd Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 445 Samsung Biologics Co., Ltd Product Portfolio
Table 446 Samsung Biologics Co., Ltd: Recent Developments
Table 447 NEKTAR THERAPEUTICS Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 448 NEKTAR THERAPEUTICS Product Portfolio
Table 449 NEKTAR THERAPEUTICS: Recent Developments
Table 450 REGENERON PHARMACEUTICALS, INC. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 451 REGENERON PHARMACEUTICALS, INC. Product Portfolio
Table 452 REGENERON PHARMACEUTICALS, INC.: Recent Developments
Table 453 BioMarin PHARMACEUTICALS, INC. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 454 BioMarin PHARMACEUTICALS, INC.: Recent Developments
Table 455 Biogen Inc. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 456 Biogen Inc. Product Portfolio
Table 457 Biogen Inc.: Recent Developments
Table 458 BRISTOL-MYERS SQUIBB Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 459 BRISTOL-MYERS SQUIBB Product Portfolio
Table 460 BRISTOL-MYERS SQUIBB: Recent Developments
Table 461 Biocon Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 462 Biocon Product Portfolio
Table 463 Biocon: Recent Developments
Table 464 Abbvie Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 465 Abbvie Inc Product Portfolio
Table 466 Abbvie Inc: Recent Developments
Table 467 Amgen Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 468 Amgen Product Portfolio
Table 469 Amgen: Recent Developments
Table 470 AstraZeneca PLC Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 471 AstraZeneca PLC Product Portfolio
Table 472 AstraZeneca PLC: Recent Developments
Table 473 Eli Lilly Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 474 Eli Lilly Product Portfolio
Table 475 F. Hoffmann-La Roche Ltd Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 476 F. Hoffmann-La Roche Ltd Product Portfolio
Table 477 F. Hoffmann-La Roche Ltd: Recent Developments
Table 478 ANAPTYSBIO, INC. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 479 ANAPTYSBIO, INC. Product Portfolio
Table 480 ANAPTYSBIO, INC.: Recent Developments
Table 481 FDA Approved Biosimilars
List of Figures
Figure 1 Global Biologics Market Segmentation
Figure 2 “V” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 3 “U” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 4 “W” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 5 “L” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 6 Global Biologics Market Research Methodology: Top Down & Bottom Up Approach
Figure 7 Global Biologics Market Research Methodology: Data Triangulation
Figure 8 Global Biologics Market Overview
Figure 9 Porter’s Five Forces Analysis
Figure 10 SWOT Analysis
Figure 11 PEST Analysis
Figure 12 Global Biologics Market Forecast by Product Type, 2020-2030 (US$ billion, AGR %)
Figure 13 Global Biologics Market Share Forecast by Product Type, 2020, 2025, 2030 (%)
Figure 14 Global Biologics Market for Monoclonal Antibodies Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 15 “V” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 16 “U” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 17 “W” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 18 “L” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 19 Global Biologics Market for Humira Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 20 “V” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 21 “U” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 22 “W” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 23 “L” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 24 Global Biologics Market for Remicade Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 25 “V” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 26 “U” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 27 “W” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 28 “L” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 29 Global Biologics Market for Tysabri Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 30 “V” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 31 “U” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 32 “W” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 33 “L” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 34 Global Biologics Market for Avastin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 35 “V” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 36 “U” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 37 “W” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 38 “L” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 39 Global Biologics Market for Herceptin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 40 “V” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 41 “U” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 42 “W” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 43 “L” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 44 Global Biologics Market for Kadcyla Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 45 “V” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 46 “U” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 47 “W” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 48 “L” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 49 Global Biologics Market for Perjeta Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 50 “V” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 51 “U” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 52 “W” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 53 “L” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 54 Global Biologics Market for Opdivo Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 55 “V” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 56 “U” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 57 “W” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 58 “L” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 59 Global Biologics Market for Keytruda Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 60 “V” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 61 “U” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 62 “W” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 63 “L” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 64 Global Biologics Market for Vaccines Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 65 “V” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 66 “U” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 67 “W” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 68 “L” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 69 Global Biologics Market for Protein Therapeutics Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 70 “V” Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 71 “U” Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 72 “W” Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 73 “L” Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 74 Global Biologics Market for Insulin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 75 “V” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 76 “U” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 77 “W” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 78 “L” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 79 Global Biologics Market for Lantus Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 80 “V” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 81 “U” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 82 “W” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 83 “L” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 84 Global Biologics Market for Novolog Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 85 “V” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 86 “U” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 87 “W” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 88 “L” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 89 Global Biologics Market for Humalog Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 90 “V” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 91 “U” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 92 “W” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 93 “L” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 94 Global Biologics Market for Levemir Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 95 “V” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 96 “U” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 97 “W” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 98 “L” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 99 Global Biologics Market for Apidra Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 100 “V” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 101 “U” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 102 “W” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 103 “L” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 104 Global Biologics Market for Other Recombinant Hormones Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 105 “V” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 106 “U” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 107 “W” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 108 “L” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 109 Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 110 “V” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 111 “U” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 112 “W” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 113 “L” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 114 Global Biologics Market for Interferons Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 115 “V” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 116 “U” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 117 “W” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 118 “L” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 119 Global Biologics Market for Avonex Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 120 “V” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 121 “U” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 122 “W” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 123 “L” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 124 Global Biologics Market for Rebif Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 125 “V” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 126 “U” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 127 “W” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 128 “L” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 129 Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 130 “V” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 131 “U” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 132 “W” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 133 “L” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 134 Global Biologics Market for Regenerative Medicines Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 135 “V” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 136 “U” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 137 “W” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 138 “L” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 139 Global Biologics Market for Stem Cell Therapy Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 140 “V” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 141 “U” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 142 “W” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 143 “L” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 144 Global Biologics Market for Osteocel Plus Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 145 “V” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 146 “U” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 147 “W” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 148 “L” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 149 Global Biologics Market for Trinity Evolution & Trinity Elite Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 150 “V” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 151 “U” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 152 “W” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 153 “L” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 154 Global Biologics Market for Tissue Engineered Products Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 155 “V” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 156 “U” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 157 “W” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 158 “L” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 159 Global Biologics Market for Apligraft Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 160 “V” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 161 “U” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 162 “W” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 163 “L” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 164 “V” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 165 “U” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 166 “W” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 167 “L” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 168 Global Biologics Market for Dermagraft Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 169 Global Biologics Market for IMIGYLC Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 170 “V” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 171 “U” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 172 “W” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 173 “L” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 174 Global Biologics Market for Fusion Proteins Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 175 “V” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 176 “U” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 177 “W” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 178 “L” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 179 Global Biologics Market for Enbrel Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 180 “V” Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 181 “U” Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 182 “W” Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 183 “L” Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 184 Global Biologics Market for Eylea Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 185 “V” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 186 “U” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 187 “W” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 188 “L” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 189 Global Biologics Market Forecast by Application Type, 2020-2030 (US$ Billion, AGR %)
Figure 190 Global Biologics Market Share Forecast by Application Type, 2020, 2025, 2030 (%)
Figure 191 Global Biologics Market for Oncology Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 192 “V” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 193 “U” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 194 “W” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 195 “L” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 196 Global Biologics Market for Autoimmune Diseases Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 197 “V” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 198 “U” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 199 “W” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 200 “L” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 201 Global Biologics Market for Infectious Diseases Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 202 “V” Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 203 “U” Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 204 “W” Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 205 “L” Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 206 Global Biologics Market for Cardiovascular Disorders Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 207 “V” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 208 “U” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 209 “W” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 210 “L” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 211 Global Biologics Market for Hematological Disorders Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 212 “V” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 213 “U” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 214 “W” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 215 “L” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 216 Global Biologics Market for Others Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 217 “V” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 218 “U” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 219 “W” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 220 “L” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 221 Global Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Figure 222 Global Biologics Market Share Forecast by Manufacturing, 2020, 2025, 2030 (%)
Figure 223 Global Biologics Market for Outsourced Manufacturing Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 224 “V” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 225 “U” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 226 “W” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 227 “L” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 228 Global Biologics Market for In-house Manufacturing Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 229 “V” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 230 “U” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 231 “W” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 232 “L” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
Figure 233 Global Biologics Market Forecast by Region 2020-2030 (US$ Billion)
Figure 234 Global Biologics Market Share Forecast by Region 2020, 2025, 2030 (%)
Figure 235 North America Biologics Market Forecast by Country, 2020-2030 (US$ Billion)
Figure 236 North America Biologics Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 237 North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
Figure 238 North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
Figure 239 North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
Figure 240 U.S. Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 241 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 242 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 243 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 244 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 245 Canada Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 246 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 247 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 248 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 249 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 250 Europe Biologics Market Forecast by Country, 2020-2030 (US$ Billion)
Figure 251 Europe Biologics Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 252 Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
Figure 253 Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
Figure 254 Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
Figure 255 Germany Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 256 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 257 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 258 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 259 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 260 UK Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 261 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 262 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 263 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 264 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 265 France Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 266 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 267 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 268 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 269 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 270 Italy Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 271 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 272 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 273 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 274 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 275 Spain Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 276 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 277 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 278 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 279 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 280 Russia Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 281 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 282 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 283 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 284 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 285 RoE Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 286 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 287 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 288 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 289 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 290 Asia-Pacific Biologics Market Forecast by Country, 2020-2030 (US$ Billion)
Figure 291 Asia-Pacific Biologics Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 292 Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
Figure 293 Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
Figure 294 Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
Figure 295 Japan Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 296 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 297 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 298 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 299 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 300 China Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 301 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 302 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 303 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 304 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 305 India Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 306 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 307 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 308 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 309 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 310 Australia Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 311 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 312 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 313 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 314 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 315 RoAP Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 316 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 317 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 318 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 319 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 320 Latin America Biologics Market Forecast by Country, 2020-2030 (US$ Billion)
Figure 321 Latin America Biologics Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 322 Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
Figure 323 Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
Figure 324 Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
Figure 325 Brazil Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 326 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 327 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 328 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 329 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 330 Mexico Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 331 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 332 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 333 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 334 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 335 RoLA Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 336 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 337 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 338 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 339 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 340 MEA Biologics Market Forecast by Country, 2020-2030 (US$ Billion)
Figure 341 MEA Biologics Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 342 MEA Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
Figure 343 MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
Figure 344 MEA Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
Figure 345 GCC Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 346 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 347 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 348 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 349 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 350 South Africa Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 351 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 352 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 353 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 354 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 355 RoMEA Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
Figure 356 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
Figure 357 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
Figure 358 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
Figure 359 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
Figure 360 Biologics Market for Monoclonal Antibodies: Company Share Analysis (%), 2019
Figure 361 GlaxoSmithKline Plc Financials, 2015-2019 (US$ million, AGR %)
Figure 362 Johnson & Johnson Financials, 2015-2019 (US$ million
Figure 363 Merck & Co Financials, 2015-2019 (US$ million, AGR %)
Figure 364 Novartis AG Financials, 2015-2019 (US$ million, AGR %)
Figure 365 Pfizer Inc Financials, 2015-2019 (US$ million, AGR %)
Figure 366 Sanofi S.A Financials, 2015-2019 (US$ million, AGR %)
Figure 367 Novo Nordisk A/S Financials, 2015-2019 (US$ million, AGR %)
Figure 368 Takeda Pharmaceutical Financials, 2015-2019 (US$ million, AGR %)
Figure 369 Gilead Sciences Inc Financials, 2015-2019 (US$ million, AGR %)
Figure 370 Alexion Pharmaceuticals, Inc Financials, 2015-2019 (US$ million, AGR %)
Figure 371 UCB SA Financials, 2015-2019 (US$ million, AGR %)
Figure 372 Samsung Biologics Co., Ltd Financials, 2015-2019 (US$ million, AGR %)
Figure 373 NEKTAR THERAPEUTICS Financials, 2015-2019 (US$ million, AGR %)
Figure 374 REGENERON PHARMACEUTICALS, INC. Financials, 2015-2019 (US$ million, AGR %)
Figure 375 BioMarin PHARMACEUTICALS, INC. Financials, 2015-2019 (US$ million, AGR %)
Figure 376 Biogen Inc. Financials, 2015-2019 (US$ million, AGR %)
Figure 377 BRISTOL-MYERS SQUIBB Financials, 2015-2019 (US$ Million, AGR %)
Figure 378 Biocon Financials, 2015-2019 (US$ Million, AGR %)
Figure 379 Abbvie Inc Financials, 2015-2019 (US$ million, AGR %)
Figure 380 Amgen Financials, 2015-2019 (US$ million, AGR %)
Figure 381 AstraZeneca PLC Financials, 2015-2019 (US$ million, AGR %)
Figure 382 Eli Lilly Financials, 2015-2019 (US$ million, AGR %)
Figure 383 F. Hoffmann-La Roche Ltd Financials, 2015-2019 (US$ million, AGR %)
Figure 384 ANAPTYSBIO, INC. Financials, 2015-2019 (US$ million, AGR %)
Abbvie Inc
Adaptive Biotechnologies
Alexion Pharmaceuticals, Inc
Allergan
Amgen
Anaptysbio, Inc.
Array BioPharma Inc.
AstraZeneca PLC
Bevespi Aerosphere
Biocon
Biogen Inc.
BioMarin Pharmaceuticals, Inc.
BioNTech SE
Bioverativ Inc.
Bluebird bio, Inc.
Bristol-Myers Squibb Premier
Clover Pharmaceuticals
Colorado Center for Personalized Medicine (CCPM)
Corvidia Therapeutics Inc.
Daiichi Sankyo
Denali Therapeutics Inc.
DiNAQOR AG
Eisai, Co., Ltd.
Eli Lilly
F. Hoffmann-La Roche Ltd
Food and Drug Administration
Frazier Healthcare Partners
Gilead Sciences Inc
GlaxoSmithKline plc
Health Canada
HitGen Inc.
Humanigen, Inc
Johnson & Johnson
Kyowa Hakko Kirin Co., Ltd.
Luye Pharma Group
Merck & Co
National Medical Products Administration (NMPA)
Nektar Therapeutics
Neurocrine Biosciences
Novartis AG
Novo Nordisk A/S
Pfizer Inc.
Portola Pharmaceuticals, Inc.
Q-State Biosciences
Regeneron Pharmaceuticals, Inc.
Rice University
Samsung Biologics Co., Ltd
Sangamo
Sanofi S.A
Spark Therapeutics , Inc.
Takeda Pharmaceutical
Tango Therapeutics
Teneobio, Inc.
TESARO, Inc
Therachon Holding AG,
UCB SA
United States Biologics License Application (BLA)
World Federation of Hemophilia (WFH)
Zai Lab Reveal
List of Organizations
Agência Nacional de Vigilância Sanitária (ANVISA)
Australia's Walter and Eliza Hall Institute
Boston Children's Hospital
Center for Disease Prevention and Control (CDC)
Central Drugs Standard Control Organisation
China Food and Drug Administration
Duke University School of Medicine
EMA (European Medicines Agency)
European Commission (EC)
European Federation of Pharmaceutical Industries and Associations
Harvard University
Human Stem Cells Institute
International Myeloma Foundation
Johns Hopkins
Musculoskeletal Transplant Foundation (MTF)
National Cancer Institute
New York Blood Center
NHS
NICE
Rice University
Saudi Food and Drug Authority
SSN Cardinal Glennon Children’s Medical Center
Stanford University
The European Generic medicines Association (EGA)
The European Group for Blood and Marrow Transplantation (EBMT)
The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)
The University of Manchester
The University of Texas
The University of Texas MD Anderson Cancer Center
Toronto University
Toronto University
UCSF (University of California, San Francisco)
United Therapeutics
University of California, Berkeley
University of Colorado Cord Blood Bank
University of Tokyo
US Center for Disease Prevention and Control (CDC)
US Food and Drug Administration
Walter and Eliza Hall Institute
World Bank
World Health Organization (WHO)
Adaptive Biotechnologies
Alexion Pharmaceuticals, Inc
Allergan
Amgen
Anaptysbio, Inc.
Array BioPharma Inc.
AstraZeneca PLC
Bevespi Aerosphere
Biocon
Biogen Inc.
BioMarin Pharmaceuticals, Inc.
BioNTech SE
Bioverativ Inc.
Bluebird bio, Inc.
Bristol-Myers Squibb Premier
Clover Pharmaceuticals
Colorado Center for Personalized Medicine (CCPM)
Corvidia Therapeutics Inc.
Daiichi Sankyo
Denali Therapeutics Inc.
DiNAQOR AG
Eisai, Co., Ltd.
Eli Lilly
F. Hoffmann-La Roche Ltd
Food and Drug Administration
Frazier Healthcare Partners
Gilead Sciences Inc
GlaxoSmithKline plc
Health Canada
HitGen Inc.
Humanigen, Inc
Johnson & Johnson
Kyowa Hakko Kirin Co., Ltd.
Luye Pharma Group
Merck & Co
National Medical Products Administration (NMPA)
Nektar Therapeutics
Neurocrine Biosciences
Novartis AG
Novo Nordisk A/S
Pfizer Inc.
Portola Pharmaceuticals, Inc.
Q-State Biosciences
Regeneron Pharmaceuticals, Inc.
Rice University
Samsung Biologics Co., Ltd
Sangamo
Sanofi S.A
Spark Therapeutics , Inc.
Takeda Pharmaceutical
Tango Therapeutics
Teneobio, Inc.
TESARO, Inc
Therachon Holding AG,
UCB SA
United States Biologics License Application (BLA)
World Federation of Hemophilia (WFH)
Zai Lab Reveal
List of Organizations
Agência Nacional de Vigilância Sanitária (ANVISA)
Australia's Walter and Eliza Hall Institute
Boston Children's Hospital
Center for Disease Prevention and Control (CDC)
Central Drugs Standard Control Organisation
China Food and Drug Administration
Duke University School of Medicine
EMA (European Medicines Agency)
European Commission (EC)
European Federation of Pharmaceutical Industries and Associations
Harvard University
Human Stem Cells Institute
International Myeloma Foundation
Johns Hopkins
Musculoskeletal Transplant Foundation (MTF)
National Cancer Institute
New York Blood Center
NHS
NICE
Rice University
Saudi Food and Drug Authority
SSN Cardinal Glennon Children’s Medical Center
Stanford University
The European Generic medicines Association (EGA)
The European Group for Blood and Marrow Transplantation (EBMT)
The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)
The University of Manchester
The University of Texas
The University of Texas MD Anderson Cancer Center
Toronto University
Toronto University
UCSF (University of California, San Francisco)
United Therapeutics
University of California, Berkeley
University of Colorado Cord Blood Bank
University of Tokyo
US Center for Disease Prevention and Control (CDC)
US Food and Drug Administration
Walter and Eliza Hall Institute
World Bank
World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Biologics Market Report 2020-2030Related reports
-
Biopharmaceuticals Contract Manufacturing Market Report 2020-2030
As of 2019, the global biopharmaceuticals market’s size was estimated at ~$232 billion. It is expected to grow at a...
Full DetailsPublished: 04 March 2020 -
Global Stem Cell Technologies and Applications Market 2020-2030
The global stem cell technologies and applications market is estimated to have reached US $17,791.8 million 2020 and is expected...
Full DetailsPublished: 24 March 2020 -
Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2020-2030
Overall world revenue for CMO of sterile injectable drugs will surpass US$55.33 billion by 2030, our work calculates. We predict...
Full DetailsPublished: 01 May 2020 -
Vaccine Delivery Devices Market Report 2021-2031
Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product...Full DetailsPublished: 06 January 2021 -
Global Contract Research Organisations (CROs) Market Report Forecasts 2020-2030
Visiongain assesses that the clinical research organizations (CROs) market will generate revenues of $38.0 billion in 2020.
...Full DetailsPublished: 12 February 2020 -
Active Pharmaceutical Ingredient Market Report 2020-2030
Where is the Active Pharmaceutical Ingredient market heading? If you are involved in this sector you must read this newly...
Full DetailsPublished: 01 January 1970 -
Precision Medicine Market Report 2020-2030
Our 193 pages report provides 107 tables, 107 charts, and graphs. Read on to discover the most lucrative areas in...
Full DetailsPublished: 27 May 2020 -
Global Live Vaccines Market Forecast 2020-2030
The global live vaccines market was valued at $10,423.4 mn in 2019 and is anticipated to surpass $ 20,020 mn...
Full DetailsPublished: 12 March 2020 -
Global Biosimilars and Follow-On Biologics Market 2020-2030
The global biosimilars and follow-on biologics market is estimated to have reached $19.87bn in 2019 and expected to grow at...
Full DetailsPublished: 30 April 2020 -
Vaccine Contract Manufacturing Market Forecast 2020-2030
The global vaccine contract manufacturing market was worth $2,241.6m in 2019 and is expected to grow at a CAGR of...
Full DetailsPublished: 08 April 2020
Download sample pages
Complete the form below to download your free sample pages for Biologics Market Report 2020-2030Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034
The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.
11 April 2024
